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ABSTRACT
Commercial air travel is amongst the safest forms of transportation yet the
environment within the aircraft cabin to which the passenger is exposed may have
adverse physiological and psychological effects on passengers, especially for those with
pre-existing medical issues. A comprehensive, systematic review and analysis of current
literature was performed to develop evidenced-based guidelines for evaluation of
passenger fitness to fly for integration into primary care practice. Recommendations
from the most current fitness to fly guidelines and disease-specific published research
related to in-flight medical issues were evaluated and the Grades of Recommendation
Assessment, Development and Evaluation (GRADE) method was utilized to assess the
quality of available evidence and the strength of guideline recommendations.
The clinical practice guideline provides an overview of the major health systems
affected by air travel and conditions that warrant healthcare provider review for clearance
to fly. The need exists for randomized trials and large group research to further identify
and evaluate health conditions that are impacted or affected by commercial air travel.
True incidence of health related issues and further guidance for research would benefit
from the establishment of a universal health related incidence reporting method or
repository to collect data of in-flight health events. The guidelines developed as a result
of this capstone report will change practice and contribute to the development of
evidence-based guidance to primary care providers and clinicians who are required to
provide fitness to fly clearance exams for commercial airline passengers.
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CHAPTER 1
Introduction

Commercial passenger air travel has increased exponentially over recent years as
a result of economic growth, increased affordability of air travel as a mode of
transportation and appreciably larger long-range aircraft. Every day over 1.7 million
passengers travel by air within the U.S. and annually approximately 2 billion people
travel in commercial aircraft (Kim & Lee, 2007; Silverman & Gendreau, 2009). Current
research of population and travel demographics estimate that the number of passengers
traveling by commercial aircraft will double in the next 20 years (Patel & Simon, 2010).
Increased globalization and improved medical care combined with an rapidly expanding
number of aging and overweight population pose risks to air travelers who may not have
previously considered air as a mode of travel (Budd et al., 2011; Valani, Cornacchia, &
Kube, 2010).
By 2030, current estimates predict that at least half of all airline passengers will
be over the age of 50 years (Sand, Bechara, Sand, & Mann, 2009). The mean age of
passengers who suffer from in-flight medical events is 44 years for men and 49 years for
women. Passengers older than 70 years have the highest rate of in-flight health related
events (Silverman & Gendreau, 2009). The increasing number of elderly and more
infirmed airline passengers in conjunction with the improved commercial airline ability
to accommodate disabilities escalates the potential risk for more in-flight medical events
(Valani et al., 2010).
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Although air travel is amongst the safest forms of transportation, the environment
within the aircraft cabin to which the passenger is exposed may have adverse
physiological and psychological effects on passengers, especially for those passengers
with pre-existing medical issues. Air travel, especially over long distances, exposes
passengers to multiplicity risk factors that can result in adverse effects on at-risk
passenger’s general health and welfare (Budd, Warren, & Bell, 2011). Passengers with
pre-existing health conditions are at greater risk and should consult their primary care
provider, specialist, or a travel medicine clinic before embarking on commercial airplanes
(Silverman & Gendreau, 2009; Patel & Simon, 2010).
Commercial aircraft passenger’s failure to disclose pertinent health information as
well as failure of primary care providers to understand the risk of air travel and provide
preventive health education to their patients can result increased incidence of preventable
in-flight medical emergencies. A study by Burnett (2006) found that greater than 95% of
persons with preexisting health conditions who travel by air stated that they would like to
receive more medical advice from their healthcare provider. Routine medical histories
and screening procedures rarely, if ever, involve questions related to travel or mode of
travel (Price et al., 2011). Primary care providers concerned for passengers with preexisting health problems need to be educated on the effect of air travel on these preexisting health conditions to incorporate pre-travel precautions in their preventive health
education in order to minimize risks to their patients (Silverman & Gendreau, 2009).
The ubiquity of commercial air travel as a dominant mode of transportation and
ignorance of the potential health threats imposed upon passengers by the aircraft cabin
environment can lead to emergency health issues and disrupted flight plans. Aviation
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medicine has long been the domain of the military and aircraft industry. The majority of
aviation research on the effects of flight physiology and fitness to fly focused on the pilot
and crewmembers who are routinely subject to health screening for employment and by
virtue of the health-related occupational requirements are in better health than the average
traveling passenger. Travel by air may not only exacerbate pre-existing medical
conditions but may result in new onset of medical conditions that occur as a result of
altitude and the cabin environment. Medical emergencies can occur in-flight if traveling
passengers do not disclose pertinent health information or their healthcare providers do
not understand the potential health threats imposed on a passenger by the commercial
passenger cabin environment and air travel (Valani et al., 2010; Archard & Nicholson,
2007). Aviation medicine is not typically addressed in primary care provider education
and there is a general lack of awareness of the health effects of flying amongst primary
care providers (Wise, 2008).
Ultimately the commercial air carrier is responsible for making the determination
whether or not a passenger is capable to fly on their airline (Patel & Simon, 2010). Most
airlines do not have medical personnel on staff to perform this function and there is no
lone universally established clearance process or screening methodology utilized by the
airlines for their passengers. The air carrier possesses the right to request that a passenger
obtain a fitness to fly certificate or other documentation related to the passenger’s health
condition and their needs associated with air travel if the airline has reason to believe that
a passenger’s health may be at risk during flight or may impact the flight plans. In
instances where pre-authorization fitness to fly is requested, the airline will rely on the
documentation provided by the passenger’s health care provider to make their decision
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related to risks associated with travel by air (Patel & Simon, 2010). Regardless of
whether or not a travelling passenger requests documentation from their primary care
provider for fitness to fly, it is a responsibility of the primary care provider to include
travel related preventive health counseling to patients, especially for those patients with
pre-existing health conditions that can be adversely affected by air travel.
At present there are neither universal reporting methods nor a central registry for
health related air travel incidents (Rushkin, 2009). Each airline tracks its own diversions
and medical events and has its own method of classifying the cause of the event. As a
result, accurate epidemiologic data related to the incidence and severity of air travel
related medical emergencies does not exist (Sand et al., 2009). Flight diversions due to
medical emergencies cause significant financial and legal costs to airlines and can place a
passenger at risk for suboptimal care due to the lack of appropriate emergency
medications, equipment and skilled personnel onboard at the time of the incident as well
as at the end destination (Valani et al., 2010).
It has estimated that the frequency of in-flight medical incidents ranges from 1 per
10,000 to 1 per 40,000 passengers with approximately 1 in 150,000 of these incidents
resulting in the use of in-flight medical equipment or medications (Gallagher, Marienau,
Illig, & Kozarsky, 2012). Flight crew receive minimal training related to the use of
medical equipment and medication and rely on available healthcare personnel flying as
passengers or, when available, on air-to-ground medical advice services. Vasovagal
syncope, gastrointestinal events, respiratory events, cardiac events and neurologic events
are the most commonly encountered in-flight medical events (Gallagher et al., 2012).
Although fourth most common in incidence, cardiac events account for approximately
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two-thirds of the estimated 0.3 per 1 million passenger deaths aboard commercial flights
(Gallagher et al., 2012).
There is no standard regulation and considerable variability exists amongst the
contents of the onboard emergency medical kit (Rushkin, 2009). Airline policies
regarding the contents of medical equipment, crew training and treatment of passengers
are at the discretion of each airline’s host country and vary by airline (ASMA, 2003).
Typically cabin crew are trained in first aid, resuscitation procedures and how to
recognize medical conditions that may cause an emergency as well as how to
appropriately act upon and manage such emergencies in flight (World Health
Organization (WHO, 2005).

Regulations related to the presence of a medical kit

onboard of a commercial aircraft outside of the U.S. vary and may be limited, especially
on economy airlines (Rushkin, 2009).
Appendix A provides the most recent recommendations for the contents of the
emergency medical kit by the Aerospace Medical Association (IATA, 2011).

Most

commercial airlines operating today also carry automated external defibrillator and many
use on-ground telemedical assistance to provide medical advice and support for
passengers suffering from in-flight medical issues (Silverman & Gendreau, 2009). In the
United States, the Federal Aviation Administration (FAA) requires U.S. airlines carrying
30 or more passengers to have medical kits onboard but does not regulate the contents of
the kits carried.
Flight diversions and incidences of in-flight medical events could be reduced
through pre-travel medical evaluation and screening. The Aerospace Medical
Association found that 62% of in-flight medical emergencies were associated with pre-
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existing passenger medical conditions (Valani et al., 2010). Unfortunately, while the
number of passengers seeking medical clearance is increasing, so is the rate of diversions
per million revenue-passenger miles flown. Valani et al. (2010), posit that this may
indicate that more passengers are flying with more severe medical conditions and support
further research correlating pre-screening with passenger-related diversion.
Primary care health providers are confronted today with a limited amount of time
to assess and manage patients and regulations related to reimbursement associated with
the practice of evidenced based medicine. Many of the chronic health conditions which
place commercial airline passengers at risk are managed by primary care providers who
can be called upon by an airline to make a determination of whether or not a passenger is
safe to travel. Health risks associated with air travel can be minimized if the passenger
receives pre-travel preventive health education as well as advice for planning for travelrelated disruption or emergencies that may adversely affect the passenger’s health
(Silverman & Gendreau, 2009). An evidenced-based resource for primary care providers
to utilize in assessing the physiologic and environmental stressors associated with
commercial air travel and making the determination for a passenger’s fitness to fly is
needed and could be used by primary care providers to guide both screening and
healthcare decision-making.
Fitness to Fly
Fitness to fly is the clearance by medical personnel which authorizes a passenger
to travel and identifies any specific air travel-related needs in order to minimize the
passenger’s health risks. The IATA (2011) recommends that airlines request medical
certificates for clearance to fly from a passenger’s personal healthcare provider. Health
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care professionals who are not familiar with the environmental and physiologic
challenges of air travel may unknowingly place themselves and their patients at risk by
completing requested fitness to fly medical clearances.
The IATA (2011) identifies the following instances when medical clearance is
required prior to air travel if the passenger:
a. suffers from any active contagious or communicable disease (Appendix B)
b. may be at risk or cause discomfort to other passengers because of a physical
or behavioral condition:
c. may pose a potential safety hazard or affect the punctuality of a flight
including the possibility of flight diversion or an unscheduled landing;
d. requires special assistance and is incapable of caring for themselves:
e. has an underlying medical condition that may be adversely affected by air
travel or the aircraft environment.
Passengers who do not meet any of the medical clearance criteria noted above do not
routinely require medical clearance but those with pre-existing medical conditions may
still be at risk and routine screening and preventive guidance should be included in
primary care practice. The recommendations provided by the IATA are developed by a
working group of twelve aviation medical experts and the publication notes that there is
“very limited amount of research data on this material and most of the guidelines are
based on practical experience (IATA, 2011, p. 52).” Airline personnel have the right to
request a medical clearance for passengers who pose a concern to passenger or aircraft
safety because of observed behaviors or symptoms of illness that occur prior to, during,
or after air travel. Each airline has the right to design its own procedure related to
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documentation and wording requirements for medical clearance to fly and airlines may
deny boarding to passengers who appear to have communicable diseases or health
problems (IATA, 2011; WHO, n.d.).
The British Medical Association (2004) suggested the following considerations
that should be taken into account when assessing a patient's fitness to fly:
The effect of mild hypoxia and decreased cabin air pressure.
The effect of decreased range of motion and/or immobility
The ability in the event of an emergency landing to perform the bracing
position.
The timing of prescribed medications for long distance travel.
The psychological and physiological effects and the patient's ability to
cope with travel to and through the airport including embarkation and
disembarkation.
The potential for a patient's medical condition to adversely affect aircraft
operation and/or the comfort or safety of other passengers.
Travel health insurance, or financial resources, of the patient to deal with
potential healthcare costs in case of problems that develop from travel.
Effective travel health consultation relies not only on an understanding of the
physiologic and psychological effects of flight on health conditions but also on
appropriate risk assessment and risk management (Simons & Wong, 2011). Risk
assessment should include traveler specific risks as well as travel itinerary, medical
facilities and resources at the planned destination and planned travel-related activities that
may pose specific risks. Identification of potential travel-related hazards and the relative
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risk that they pose on an individual's health and able the healthcare provider and traveler
to plan appropriately for preventive measures as well as to develop a plan for travel
related emergencies and post travel evaluation.
The patient's primary care provider is often called upon to provide a passenger
clearance to fly and in order to do so needs to have a thorough understanding of the
physiologic effects of air travel on a patient's health and well-being. The most
appropriate time to address fitness to fly for passengers is well in advance of travel. As
part of a preventive education plan, the healthcare provider can review with the patient
concerns related to the effects of travel on their medical condition, timing of medication,
immunizations and hygiene measures to reduce exposure to infectious disease and
contagions and the need for any additional special assistance or devices in order to
promote safe travel. Cardiovascular disease, deep venous thrombosis, respiratory
disease, surgical conditions, neurologic disorders, mental illness, pregnancy and chronic
medical issues such as diabetes should trigger a discussion of pre-travel preventive
medical education between a healthcare provider and their patient. Healthcare providers
who have questions or concerns related to their patient’s fitness to fly should contact the
passenger’s airline medical department or consider referral of the patient to a travel
medicine specialist for fitness to fly medical certification.
Purpose of the Study
This capstone project set out to develop clinical practice guidelines (CPG) for
primary care providers to utilize in establishing commercial passenger fitness to fly. The
specific aims of the capstone project were
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1)

to identify the physiologic and environmental hazards associated with
air travel that place a commercial airline passenger at risk,

2)

to review current guidelines on common health issues associated with
commercial air travel,

3)

to analyze and synthesize current research findings in the identified
health areas

4)

to compile all data from the specific aims in an evidenced-based clinical
practice guideline for dissemination via publication and use by primary
care providers in determining passenger fitness to fly.

Policy Implications
The development of a CPG will change practice and provide evidence-based
guidance to primary care providers and clinicians who are required to provide fitness to
fly clearance exams for commercial airline passengers. Publication by a peer-reviewed
professional nurse practitioner journal will provide an avenue for dissemination of the
CPG amongst the primary care provider community and support future CPG
development by nurse practitioners.
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CHAPTER 2
Review of Literature
The aircraft cabin environment places several different environmental and
physiologic challenges upon passengers that do not routinely occur in other modes of
public transportation. During normal operation scientific evidence has not shown that the
standard aircraft cabin environment poses any risks to healthy passengers (IATA, 2011).
However, the unique aspects of the aircraft cabin environment may pose problems for
passengers who may be traveling in less than optimum health or for those who may have
underlying health conditions that can be affected by the physiologic challenges associated
with commercial flight. More passengers are traveling, including more elderly persons
and patients with pre-existing medical issues that are at-risk for the adverse effects that
the aircraft travel conditions may present. An understanding of the aircraft cabin
environment under normal operating circumstances is essential for healthcare providers
who are making decisions related to a potential passenger’s fitness to fly.
Hypobaric Hypoxia
Modern commercial aircraft are pressurized to maintain a fairly constant air
pressure. The primary difference between travel by air and by ground transportation is the
difference in pressurization which is not equivalent to ground level barometric pressure
(IATA, 2011). Boyle’s law states that with altitude, the volume of a gas expands and so
has a lower pressure. As the aircraft ascends, cabin pressure decreases and resulting in
gas volume expansions up to 30% (Patel & Simon, 2010). While most commercial
aircraft cruise at an altitude between 35,000 and 40,000 feet, cabin air pressure varies
between the external environmental pressure at the altitude of the airport when the plane
11

is not in flight up to what is the airline industry accepted maximum air pressure equal to
8,000 feet altitude.
Aircraft are pressurized by bleeding air from the engines. The pressurization
system draws air from different stages of the engines (which act as compressors) before it
enters the combustion chamber and redirects it to the internal aircraft environment
(IATA, 2011). The assistance of an outflow valve allows the pressure to be raised and
maintained to a predetermined desirable level. The maximum desired pressurization
level of 8000 feet was selected based upon studies demonstrating that at that level the
average healthy aircraft passenger hemoglobin oxygen saturation normally remains above
ninety percent. The 8,000 foot level is not an international aviation requirement but
rather an industry-related practice that is meant to provide a concession between an
acceptable level of mild hypoxia, a comfortable environment for traveling passengers,
acceptable pressurization upon the aircraft, minimal structural weight penalty and
economical fuel usage (Aerospace Medical Association, 2008). The recommendation
was put in place decades ago before the changing demographics of traveling passengers
and questions exist as to whether or not the recommended maximum equivalent pressure
is still valid in today’s environment where passengers may be older and suffering from
acute or chronic health conditions (IATA, 2011).
In the United States, Federal Aviation Regulations require that an aircraft be
capable of maintaining no greater than 8,000-ft cabin altitude at the maximum operating
altitude but there is variability in aircraft cabin pressure with altitude and one in-flight
study demonstrated cabin altitudes as high as 8915 feet (Aerospace Medical Association,
2008). Cabin air pressure is not maintained at a constant level during long-haul
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commercial flight and decreases as aircraft cruise at higher altitudes in the latter part of
longer flight sectors (Kelly, Seccombe, Rogers, & Peters, 2007). Fitness to fly
evaluations related to concerns for hypobaric hypoxia and related complications can be
confounded by studies that have demonstrated cabin pressure simulation tests expose
subjects to more hypoxic conditions than will be experienced during flight on a Boeing
747 (Kelly et al., 2007). Despite the possibility that cabin simulation studies may pose
the potential for more hypoxia than a passenger may encounter in a true flight
environment, it would be prudent to evaluate a potential passenger at risk during hypoxia
at a lower standard to account for the variability in cabin environment, potential inability
of an airline to support supplemental in-flight oxygen and the passenger’s inability to
control for altitude during flight. Passengers at risk for hypoxia at other high altitude
environments will likely suffer from hypoxia in a cabin environment that is pressurized to
8,000 feet.
Aircraft flying at higher altitudes are more fuel-efficient and avoid turbulence for
passengers comfort and for that reason it is estimated that many aircraft do exceed the
8,000 feet pressurization limit at some time during a flight pattern. Prediction of cabin
altitude for any flight is difficult because the actual cabin altitude experienced is
dependent upon variables such as aircraft model, weather patterns, and air traffic control
(Kelly et al., 2009). At cruising altitude there is a significant reduction of barometric
pressure compared to the barometric metric pressure found at sea level which results in a
concomitant decrease in the partial pressure of alveolar oxygen (PaO2) resulting in
passenger hypoxemia (Patel & Simon, 2010; Aerospace Medical Association, 2008).
PaO2 levels typically decrease from 103 mmHg at sea level to around 70 mm Hg while in
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flight. The end result is a drop in oxygen saturation levels by 3% when travelling at
3,000 feet and at the highest cabin altitude of 8000 feet equates to an oxygen saturation of
85 to 9% (Patel & Simon, 2010; Johnston, 2009).
Dozing passengers have been found to have oxygen saturation levels around 80%
(Hinninghofen & Enck, 2006). The normal maximum cabin pressure is 750 hPa which is
approximately equal to the pressure when breathing 15% oxygen at a typical sea level
pressure of 1016 hPa (Kelly, Seccombe, Rogers, & Peters, 2007). Most healthy
passengers experience an average pulse oximetry of 92% in-flight and can compensate
for the decreased oxygen saturation (Kelly et al., 2007). The resultant decrease in
oxygen saturation can exacerbate pre-existing conditions for some passengers bringing
them to the steep part of the oxyhemoglobin dissociation curve resulting in very low
oxygen saturation and may pose a health risk to coronary, pulmonary, cerebrovascular,
ocular or hemodynamically challenged passengers as well as others suffering from acute
medical issues (IATA, 2011; Bayer, Mutlu, Akay, & Bayraktar, 2008; ASMA, 2003).
In the United States there is no requirement for all passengers to be provided with
supplemental oxygen until the internal cabin pressure altitude exceeds 15,000 feet
(Aerospace Medical Association, 2008). Passengers over the age of 40 experience a
steady decrease in oxygen saturation that is estimated at a decrease of 5 mmHg per 10
years. Elderly passengers as a result of decline in respiratory condition associated with
aging, have even lower daily oxygen saturation levels. When elderly passengers combine
lower daily oxygen saturation levels with a decrease due to increased altitudes and cabin
air pressure they may experience hypobaric hypoxia. Hypoxia can have multiple effects
on the circulatory system including: local vasodilatation of coronary and cerebral
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vascular beds, increased heart rate, increased systemic blood pressure, increased
myocardial contractility, increase in cardiac output and an increase in pulmonary artery
pressure (Smith et al., 2010). The issue of hypobaric hypoxia can be further compounded
in passengers who consume alcohol due to the resultant increased hypoxic effect of
alcohol on the brain (Girasek & Olsen, 2009).
Hyperbaric Chamber (HC) exposure to flight simulated hypoxia and hypoxiaaltitude simulation test (HAST) are amongst the standard tests utilized to replicate the
hypoxia of air travel at 8,000 feet, these tests may not be readily available and may be
cost-prohibitive for pre-flight evaluation of commercial air passengers (Figure 6).
A recent randomized cross-over study of oxygen titration during a HAST and in a HC
was performed in which the data suggested that titration of supplemental oxygen via a
nasal cannula during a HAST may provide falsely high PaO2 values as a result of oxygen
accumulation in the facemask and therefore the HAST results may not be utilized with
confidence due to individual variability (Akero et al., 2011). Additional concerns
resulting from the Akero et al. study (2011) include the results of their evaluation of
various type of oxygen equipment in the HC and their findings that the use of a portable
oxygen concentrator (POC) resulted in lower PaO2 values. The POC at a pulse setting of
two gave a PaO2 ≥ 5.7kPa (50mm Hg) and was needed to reach an SpO2 ≥ 90% in most
of the patients evaluated. Physical activity, including walking, in flight resulted in a
drop of SpO2 requiring even higher doses of supplemental oxygen. Akero et al. (2011)
recommend that based upon the findings of their study patients traveling with POC
should increase their oxygen flow compared with supplemental oxygen given with
compressed gaseous oxygen systems.
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Pulse oximetry can be utilized pre-flight and in-flight to monitor and titrate
oxygen levels. A small study (n=14) of oxygenation response to air travel in subjects
without obstructive lung disease and not receiving supplemental oxygenation
demonstrated that air travel resulted in desaturation including further declines associated
with walking during the flight (Kelly et al., 2009). Although in the Kelly et al. (2009)
study there was significant desaturation in subjects, reported symptoms of respiratory
distress were minimal leading to even further concerns of a flying patient with a
compromised pre-travel oxygen status to be able to effectively evaluate their symptoms
during flight. The Kelly et al. (2009) study found that baseline SpO2 was a better
predictor of in-flight desaturation than HCT. Ultimately it is imperative that clinicians
understand the individual characteristics of the patient’s oxygen control, need for
supplemental oxygen in daily life, and the pre-flight health condition of the patient, flight
duration, and altitude in order to make a determination of whether or not supplemental
oxygen may be needed.
Passengers with chronic obstructive pulmonary disease (COPD) have a limited
capability of increasing minute ventilation in response to hypoxia and the presence of an
alteration in the perfusion/ventilation ratio can make it hard to compensate during air
travel (Tzani, Pisi, Aiello, Olivieri, & Chetta, 2010). Passengers with hemoglobin levels
less than 7.5 g/dl or in sickle cell crisis have an increased need for supplemental oxygen
and may experience problems associated with decreased PaO2 levels (Aerospace Medical
Association, Aviation Safety Committee, Civil Aviation Subcommittee, 2008).
The decrease in cabin air pressure as the aircraft climbs in altitude causes gas to
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expand increasing in volume by nearly 30% which can create problems when gasses
become trapped in the body (WHO, 2011; Aerospace Medical Association, Aviation
Safety Committee, Civil Aviation Subcommittee, 2008). At 8,000 feet above sea level,
the volume of a gas increases by a factor of 1.4. The main areas affected by gas
expansion in passengers are the middle ear, the sinuses, the stomach, pleural cavities, the
skull and the bowels (IATA, 2011; Hinninghofen & Enck, 2006). Aircraft descent causes
a reduction in the trapped air which creates a vacuum in closed spaces such as the ear and
sinuses. Trapped gas leads to passenger discomfort and the potential for medical
complications in passengers with pneumothorax, recent thoracic, abdominal or ocular
surgery. Gas expansion when trapped in the ears can cause minor to severe discomfort
and possible perforation especially in infants and young children (Bagshaw, 2007).
Divers and other passengers who have been exposed to hypobaric conditions prior to
flight should wait at least 12 hours from their last dive or hypobaric incident, or 24 hours
from multiple dives before flying to prevent decompression illness (WHO, 2011).
Medical devices such as pneumatic splints, feeding tubes, urinary catheters and
cuffed endotracheal or tracheostomy tubes are affected by gas expansion and the
instillation of water rather than air can eliminate air-travel related adverse events
(Silverman & Gendreau, 2009). Gas expansion also may cause a multitude of problems
for post-operative patients especially if gas has been introduced as a result of recent
surgery such as abdominal or ophthalmologic procedures. Passengers who are in the
post-operative phase after a major or minor surgical procedure have a need for increased
oxygen due to surgical trauma, rising adrenergic outflow, and possible sepsis (Aerospace
Medical Association, Aviation Safety Committee, Civil Aviation Subcommittee, 2008).
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It is not contraindicated for pregnant women less than 36 weeks gestation, to fly on
commercial airlines however, the expansion of gas in the abdomen may cause some
discomfort (Bagshaw, 2007). Women over 28 weeks gestation may need additional
documentation from their OB/GYN prior to travel (Archard & Nicholson, 2007).
Aircraft Ventilation
Ventilation of the pressurized cabin is required to provide for passenger comfort
as well as to reduce air contaminants. Aircraft cabins are supported by two types of
ventilation systems, one which provides 100% fresh air continuously. Air that is brought
in from the engines is passed through air conditioning units to cool the air before it enters
the aircraft cabin. The cooled air is passed through the outflow valve and is replaced by
fresh air coming from the outside as well as the air conditioning system (IATA, 2011). A
second ventilation system provides a combination of fresh air and recirculated cabin air.
Recirculated cabin air is passed through a High Efficiency Particulate (HEPA) filter
which traps particulates but have no effect on gases. HEPA filters vary in their level of
efficiency and there are no federal or international regulations that require a minimum
level of efficiency in aircraft cabins (IATA, 2011). The ration of fresh air to recirculated
air in commercial planes is typically 50:50 with the entire cabin air being exchanged
approximately every 3-4 minutes (IATA, 2011). While passenger concerns may exist
related to the recirculation of air on planes, the aircraft ventilation systems are similar to
those found in commercial buildings.
One primary difference that exists between commercial building and aircraft
space is the density of population per area. Recently the transmission of disease by
biologic contaminants has gained media attention due to concerns related to cases
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involving tuberculosis and influenza transmission. The HEPA filters when installed as
part of the ventilation system are a means of trapping dust, bacteria, fungi and viruses
which may circulate within the cabin environment (Figure 9). No research to date has
supported a significant risk of disease transmission when the aircraft ventilation systems
are functioning adequately (IATA, 2011). While the proximity of passengers to a
potentially contagious person can increase transmission, the ventilation system within an
aircraft has not been shown to be a factor in disease transmission. The risk of
transmission of disease is greatest when the aircraft is on the ground and an auxiliary
power unit provides ventilation. Auxiliary ventilation is utilized before the main engines
are started, but may not always be operated due to environmental noise or technical
reasons (WHO, n.d.). Transmission of infection may occur between passengers who are
seated in the same area through direct contact with other passengers, aircraft cabin parts,
furnishings or through respiratory droplet spread during coughing or sneezing. The risk
associated with disease transmission in these circumstances is not different than the risk
posed in any other public situation where individuals are in close contact. (WHO, n.d.).
Most commercial aircraft have a laminar air flow system which moves the air
from top to bottom and not from front to back or back to front. In cases of suspect
disease transmission the laminar airflow system limits risk of transmission to only those
passengers within the immediate vicinity of a contagious passenger and not to all
passengers travelling on the plane (WHO, n.d.).
Relative Humidity
Studies have shown that air travel does not result in a change in osmolality
therefore cannot be linked to travel dehydration (Johnston, 2009). However, inside an
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aircraft cabin the humidity levels are fairly low, around 10-20%, compared to the 40 to
50% found in a standard commercial building. Flight distance exacerbates the problem
of low relative humidity and at the end of a long distance flight the humidity can be as
low as 2-3% (Hinninghofen & Enck, 2006). Low cabin humidity results from air being
drawn into the cabin from the outside air in which moisture is absent at high altitudes
(Patel & Simon, 2010). Aircraft traveling at an altitude of 35,000 feet draw in air that is
atmospherically less dense, colder and drier than air conditions found at ground level
(Budd, Bell, & Warren, 2011). Superficial dehydration results from the decreased levels
of humidity can cause dry, itchy or irritated eyes, nasal congestion and dried mucous
membranes of the nose, throat and skin (IATA, 2011; Patel & Simon, 2010; Johnston,
2008). Flight related dehydration can be compounded by the diuretic effects of
medications, alcohol and caffeine (Hinninghofen & Enck, 2006). The effect of the low
relative humidity and superficial dehydration, while temporarily uncomfortable to the
passenger, does not pose any long term effects to passenger health or well-being (IATA,
2011).
Passenger Space and Comfort

Long-haul aircraft today are capable of flying non-stop for 20 hours which makes
passenger seat spacing and comfort important for both passenger health and well-being.
Seat comfort includes seat pitch, seat width, leg room, upholstery quality and angle of
recline (Silverman & Gendreau, 2009; Hinninghofen & Enck, 2006). The minimum
dimensions between aircraft cabin seats are regulated by the aircraft standards of the
country of aircraft origin (Figure 10).
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The airline seat pitch is an indication of the available legroom and refers to the
space between a point on one seat and the same point on the seat in front of it. Seat pitch
is usually expressed in inches and ranges from 28 inches in low-cost carrier economy
class to up to 100 inches in some long-haul carrier first class sections (Hinninghofen &
Enck, 2006). More seat pitch can mean more legroom, but it is also affected by the
thickness of the seat back. Airlines have claimed that a reduction of seat pitch can be
compensated for by a thinner seat-back design. Close seat pitch is associated restricted
degree of seat tilt and the reduction in size correlates with poor passenger comfort
(Brundrett, 2001).

Seat width is measured by the distance from armrest to armrest and ranges
averages between 16-18 inches in economy class to 21-36 inches in first class. Narrow
seat widths can impede normal circulation and combined with prolonged sitting can
increase the risk of deep vein thrombosis and edema (Brundrett, 2001). Cramped
passenger seating affects not only passenger comfort but can also make it difficult for
passengers to leave the seat for exercise and has been associated with disturbed
respiration, restricted gastrointestinal mobility and blood circulation and may result in
edema and ischemia of the lower extremities (Hinninghofen & Enck, 2006).

Long-range air travel greater than 4 hours combined with decreased liquid
consumption, increased inactivity and low humidity levels can place travelers at risk for
traveler’s thrombosis. Venous blood flow to the lower extremities is decreased by 2/3
when people are in the sitting position. Each hour people remain in the sitting position
there is further reduced venous blood flow and increased hematocrit levels combined
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with rises in plasma protein creating venous pooling “inducing hemoconcentration and
depressed fibrinolytic activity contributing to hypercoagulability” put many passengers at
risk for deep vein thrombosis (DVT) (Sandor, 2008; Brenner, 2006).

Disrupted Circadian Rhythm
The body’s natural cycle extends over a 24 hour period and is referred to as the
circadian rhythm. Jet lag is a result of the interruption or desynchronization of the
circadian rhythm. Jet lag is well tolerated by healthy individuals however with the loss or
addition of time in the rhythm cycle there may be a need for an adjustment in some
passenger medication dosages (Johnston, 2009; Aerospace Medical Association, Aviation
Safety Committee, Civil Aviation Subcommittee, 2008). East-west and west-east flights
involving rapid transit through several time zones can upset the balance between extrinsic
time and physiological time and result in indigestion, bowel disturbance, fatigue, malaise,
daytime sedation, insomnia and reduced physical and mental performance and
disorientation (WHO, 2011; Budd, Bell, & Warren, 2011). Passengers travelling east
bound lose time in their day and for those traveling west bound add time to their day.
Typically westbound flights are more easily tolerated than eastbound flights. Other
factors that may affect jetlagged include the number of time zones crossed, sleep
deprivation, and environmental stimulation associated with the activities of the internal
cabin (Patel & Simon, 2010).
Insulin dependent diabetics may need to adjust regular or long-acting insulin
dosages to account for the time change (Johnston, 2008; Bagshaw et al., 2002). Jet lag
combined with a time change can promote problems for passengers with cardiovascular
disease as well. Passengers often are confused as to when they should take their
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medications at the new or previous time zone and alterations in daily routine often result
in forgetting medications all together. People travelling with stable heart failure, angina
or arrhythmia it is very important that they maintain the regularity of their medication
(Smith et al., 2010).
Stress
All passengers are subject to travel related stress regardless of the duration of
their flight (ASMA, 2003). In addition to the physiologic stress associated with preexisting health conditions, additional stressors that may occur as a result of traveling
include walking long distances, carrying heavy baggage, and prolonged sitting in
confined spaces. Psychological stressors can impact a passengers health during travel
and can manifest as new onset or exacerbations of existing psychiatric illnesses
particularly in vulnerable individuals (Al-Zurba, Saab, & Musharrafieh, 2007;
Hinninghofen & Enck, 2006). For the average traveler potential psychological stressors
include concern and anxiety related to preparation to travel, transportation to and from
airport's, frustration associated with check-in and security procedures, and worry related
to flight delay as well as fear of flying (Patel & Simon, 2010). Business travelers have
been shown to have high to very high levels of travel stress and cited social and
emotional concerns such as isolation and the impact of travel on family as the greatest
contributor to their stress level followed by health concerns (Burkholder, Joines,
Cunningham-Hill, & Xu, 2010). Cabin noise, vibration, turbulence, varying
temperatures, and uncomfortable seating room can pose additional stressors in-flight
(ASMA, 2003). Alcohol, often consumed by anxious passengers pretravel and in-flight,
can exacerbate psychological symptoms as well as pre-existing disorders.
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Evidence Based Practice
In healthcare there are variations in practice making it both an art and a science.
The Institute of Medicine (IOM) (2008) issued a report emphasizing the need for
evidenced based practice (EBP) as a means of promoting quality care and improving
practice outcomes. Evidence-based practice requires clinicians to incorporate current
scientific research with their clinical experience while balancing the individual
characteristics and diverse needs of each patient (Turner, Misso, Harris, & Green, 2008).
Inconsistent, absent, or inaccurate use of medical research can be a source of practice
variation and ultimately lead to increased healthcare costs without improvement in
outcomes (Shiffman et al., 2009). Health care delivery and decision-making should be
rooted in the use of evidenced-based current best practice with the ultimate goal of a
standardized guideline development and implementation process which will result in
improved clinical practice and outcomes (IOM, 2008; Harrison, Legare, Graham, &
Fervers, 2010; Turner et al., 2008).
Clinical Practice Guidelines
Clinical practice guidelines are statements that contain recommendations designed
to support clinical decision-making by healthcare professionals and patients in specific
situations (IOM, 2008; Shiffman et al., 2009). CPGs should be reflective of current
scientific research and involve a systematic review and appraisal of the literature and
available evidence (Poolman, Verheyen, Kerkhoffs, Bhandari, & Shunemann, 2009;
Turner et al., 2008). The goal of CPG development is to summarize the most current
evidenced-based best practice (Shiffman et al., 2009).
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CPGs are being developed by teams of experts at local, regional and national
levels and may be subject to bias and development deficiencies depending upon the
source of the guideline development, political or economic incentives for implementation
and the priorities of the health care system in which they are being implemented
(Bondmass, 2008; Clutter, 2009; Turner et al., 2008). Shiffman et. al. (2009) identify
problems in guideline quality, language, knowledge synthesis implementation, uptake
and formulization that can impede the applicability of guidelines. The IOM Report Brief
(2008) notes that many current guidelines have been developed without the necessary
scientific rigor and their reliability may be in question due to their lack of method
transparency and failure to comprehensively and systematically assess all available
clinical evidence.
The Guideline Development Process
The CPG development process includes a formal definition of a problem for
study, review of the evidence, development of a consensus, formulation of the guideline,
dissemination of the information with the goal of translation and implantation of the
recommendations into clinical practice (Papadopoulos, 2003). A comprehensive
systematic review of the literature will provide information related to the problem being
examined as well as current knowledge related to the effectiveness of healthcare
interventions (IOM, 2008). The development of a CPG involves not only the systematic
review of the literature but the integration of the findings of the review into
recommendations for care (IOM, 2008). A panel of experts who have access to current
evidence and an understanding of the clinical problem should be involved in the
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development of the CPG as there may be inherent gaps in available research to support
clinical recommendations (IOM, 2008).
The process of CPG development should include the incorporation of two grading
systems: one system to address the quality of available evidence and another to address
the strength of study recommendation (IOM, 2008). The quality of evidence grade
represents the level of confidence that if the recommendations are followed appropriate
outcomes will occur. The grade given to the strength of the recommendation is a balance
of the risk/benefit ratio associated with the recommended interventions and the expert
panel’s interpretation of the importance associated with following guideline
recommendations (IOM, 2008).
An important determinant in the strength of the recommendation is the type of
research evaluated in the CPG review. Peer-reviewed, published controlled clinical trials
are considered to provide the best information regarding the effectiveness of a therapeutic
approach (Embree, 2000). Peer-reviewed, published epidemiologic studies provide the
next best level of evidence in support or against a therapy (Embree, 2000). The lowest
strength rating is assigned to published case report recommendations and opinions based
upon personal clinical experience of the expert panel (Embree, 2000).

The IOM (2008)

recommends that the CPG development process be scientifically rigorous, document
standards utilized, and take efforts to protect from bias so that the final published
guidelines are effective.
GRADE Method
There are several systems available for evaluating and grading clinical evidence
in the development of CPGs. The Grades of Recommendation Assessment, Development
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and Evaluation (GRADE) method was introduced in 2004 after the GRADE
developmental working group compared six existing systems and found that they lacked
consistency in agreement amongst the systems (Kavanagh, 2009). GRADE has been
accepted and adopted by national and international medical organizations, government
and healthcare regulatory agencies (Kavanagh, 2009). One advantage of the GRADE
method in comparison to other grading modalities is that it allows for CPG reviewers to
interpret, pass judgment and classify the quality of evidence classifying evidence as high,
moderate, low and very low (Gugiu & Gugiu, 2010; Jaeschke et al., 2008). The GRADE
framework allows for definition of evidence quality based upon the guideline panel’s
level of confidence related to the research validity and the benefit/risk ratio for
implementation of a given recommendation (Ansari, Tsertsvadze, & Moher, 2009).
The factors that influence the strength of a recommendation in the GRADE
framework include not only assessment of the quality of evidence but also the balance
between risk/benefit effects, values, preferences and cost of recommendation
implementation (Jaeschke et al., 2008). Strengths of the GRADE system include
transparency related to the judgments and opinions regarding the evidence and
recommendations and the fact that while weight is provided to the study design it is not a
singular factor in judging the evidence quality (Brozek et al., 2009). Expert opinion,
when applied in the GRADE system, is not a quality of evidence but serves as an
interpretation of existing evidence. The GRADE system of review recognizes the
necessity of expert opinion for the translation and integration of clinical evidence into the
final recommendation (Brozek et al., 2009). The application of the GRADE system
includes systematic literature review of all available diagnostic and management
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approaches and the summary of evidence into tables that are succinct, transparent and
informative related to the quality of the evidence, the effects of application on patient
care outcomes, and the means for determining the evidence rating (Guyatt et al., 2011).
Cardiovascular Disease
In-flight medical incidents related to cardiovascular disease are amongst the top
five recorded incidents and account for two-thirds of all in-flight passenger mortalities.
As previously discussed, the lack of an international aviation registry for passenger
related medical incidents makes it difficult to statistically quantify the number of
incidents that occur annually. Classification of in-flight related events which may be
cardiac related may also be recorded under different medical categories such as syncope
or respiratory distress (Shurlock, 2011). Recognizing the need for clear advice to guide
general practitioners, a working group of the British Cardiovascular Society was
established to develop guidelines for evaluation of fitness to fly in cardiovascular patients
(Smith et al., 2010).

The guidelines presented by the group in 2010 were focused on

conditions of the heart and great vessels alone and, in the absence of randomized
controlled trials and clinical studies of passengers with existing cardiovascular disease
the recommendations, were based on the physics and physiology of the aircraft cabin
environment along with expert opinion of the Cardiologists serving on the working group
(Shurlock, 2011).
While most patients with cardiac conditions can travel safely by air, travel
medicine experts suggest that the contraindications to commercial airline travel for
patients with cardiovascular disease are included in along with GRADE evaluation of the
quality and strength of supporting evidence presented. Patients with cardiovascular
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disease may be negatively affected by the decrease in oxygen saturation during flight
which results in hypoxia that leads to increased heart rate and subsequent cardiac demand
(ASMA, 2003). As a result in-flight oxygen is indicated for patients with the following
cardiovascular conditions:
require oxygen at their home baseline altitude
congestive heart failure class III-IV
baseline PaO2 less than 70 mm Hg
class III-IV angina
cyanotic congenital heart disease
primary pulmonary hypertension
other cardiovascular disorders associated with baseline hypoxia.
Passengers with pacemakers and implantable cardiac defibrillators are not
restricted from flying once stable. It is important to inform passengers with pacemakers
and implantable defibrillators that they need to identify themselves in advance to the
security screening personnel as they need to be screened by alternate devices other than
the standard x-ray equipment.
It is important for patients to understand that the airlines do not provide oxygen
supply for their needs during flight and that it is the patient's responsibility to make
arrangements in advance for portable oxygen that is approved for use in commercial
airline travel as well as an adequate supply of oxygen tanks to meet their needs.
Unanticipated delays related to weather, missed connections or aircraft equipment
malfunction often results in extended travel time over that which is initially planned.
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Therefore, patients should carry an excess supply of oxygen and rechargeable tanks for
use in the event of delayed travel.
Available studies evaluating the effect of flight upon cardiopulmonary physiology
principally evolve from studies of subjects living on land at high altitude or by studying
the effects of normobaric hypoxia in a laboratory setting (Smith et al., 2010). While
some characteristics of these environments can simulate the effects of traveling by
commercial aircraft the environments are not equivocal and therefore any application of
such research would have to be considered to be speculative.
No direct studies of the effect of hypoxia during commercial air travel upon
patients with cardiovascular ischemia were located and after applying the results of the
evaluated studies to the physiology of ischemia the authors concluded that there would be
little to no effect in precipitating ischemia on commercial airline passengers. A
retrospective analysis of 213 patients who were transported via commercial airlines after
acute myocardial infarction controlled hypoxia with supplemental oxygen and therefore
was unable to identify whether or not untreated hypoxic situations may have resulted in
further cardiac ischemia or events (Thomas et al., 2006).
The ability for patients with clinically stable pulmonary hypertension to tolerate
air travel was evaluated in an anonymous survey (Thamm et al., 2011). Patients with
pulmonary hypertension were identified with inclusion criteria including a confirmed
diagnosis of pulmonary arterial hypertension that were stable as identified as having no
specific therapeutic changes three months prior to travel. Patients with severe lung
diseases, left ventricular diseases and other concurrent chronic diseases were excluded
from the capstone project. A total of 720 questionnaires were distributed with 430
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returned (60% response rate). Not all of the 430 respondents had flown since their
diagnosis which resulted in only 179 diagnosed patients who had flown at least once
since their diagnosis. Of those flyers, 20 (11%) reported having had one or more adverse
events during or directly after at least one of their flights.

Adverse events reported

included dyspnea (3.4%), peripheral edema (3.4%), exhaustion (1.7%), heart palpitations
(1.1%), chest pain (1.1%), headache (1.1%), worsening of general condition (1.1%) and
fear of flying (0.6%).
Thamm et al. (2011) acknowledge in their publication the potential for selection
bias in their review. An additional noted limitation was that the hemodynamic status of
the respondents was not known prior to air travel and therefore the classification of
disease severity into WHO classes was limited to patient self-report. While the authors
suggest that air travel can be safe and well-tolerated by patients with stable pulmonary
hypertension, their final consensus was that physician evaluation is required prior to
travel for every patient. The Thamm et al. (2011) study size was small and the biases
involved bring into question the generalizability of the statement of safety. At present,
there are no data from controlled trials examining the safety of air travel for patients with
pulmonary hypertension (Thamm et al., 2011).
Respiratory Disease
Healthy passengers without underlying respiratory disease will experience a
significant desaturation during commercial air travel as a result of hypobaric hypoxia but
typically do not experience dyspnea (Kelly et al., 2008). Due to the lack of a universal
method for reporting air travel related illness and it’s cause there are no exact numbers of
passengers with respiratory conditions that are affected by air travel. What is known is
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that respiratory symptoms are the third most frequent cause of flight diversion related to a
medical issue (Ahmedzai et al., 2011). In an effort to ease decision-making for fitness to
fly in respiratory patients Tzani (2010) offered an algorithm to provide some direction for
healthcare provides to evaluate respiratory patients and estimate the potential need for
supplemental oxygen or further evaluation prior to air travel (Figure 11).
The majority of in-flight oxygen requests and pre-flight oxygen clearances are for
passengers with chronic respiratory diseases (Patel & Simon, 2010). Overall
recommendations for medical advice related to fitness to fly clearance should depend
upon the type, reversibility and functional severity of the underlying respiratory condition
and the healthcare provider’s assessment of the passenger’s ability to tolerate the
commercial aircraft cabin environment and hypobaric hypoxia in flight (Patel & Simon,
2010; UK Civil Aviation Authority, 2007). Passengers who may be subject to worsening
conditions associated with hypoxia in-flight can be cleared for travel with the assistance
of an airline approved therapeutic oxygen device.
A cross-sectional study of 391 COPD passengers and 184 non-COPD passengers
were evaluated for lung function, blood gas values, exercise capacity, air travel habits and
in-flight symptoms to determine the prevalence of in-flight symptoms in patients with
COPD (Edvardsen et al., 2011). The Edvardsen et al. (2011) study was the first known
flight outcome study comparing COPD patients with non-COPD subjects and the data
from the study showed a 3-fold increase in hypoxia related symptoms and near 7-fold
increase in dyspnea and air hunger amongst COPD patients compared to non-COPD
patients. No significant difference was noted in other air travel related symptoms such as
ear pressure, sinus pressure or edema between the groups. After adjustments were made
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for smoking status, age and gender, the odds ratio for COPD passengers to experience
dyspnea or air hunger was 6.6 (95% CI 2.5-17.3, p < 0.001) compared to non-COPD
subjects. Pre-flight scores on the Medical Research Council (MRC) Dyspnea scale were
strongly associated with in-flight dyspnea (p < 0.001) and while the possibility of recall
bias may have been a result of the design the strong association of the MRC Dyspnea
score with the observed results offers an interesting avenue for further investigation of
alternate means of evaluating respiratory patients pre-flight.
Several prior studies support Edvardsen et al. (2011) findings of increased
incidence of dyspnea in patients with COPD. The UK Flight Outcomes Study (Coker,
Shiner, & Partridge, 2007) was a prospective multicenter observational study examining
the outcomes of commercial air travel in patients with respiratory disease. Of the patients
evaluated, 243 (39%) had a diagnosis of COPD with disease severity ranging from mild
(2%), moderate (29%), severe (43%) to very severe (26%). During flight, 18% of the
patients in the UK Flight Outcomes Study reported respiratory distress manifested as
dyspnea. Similarly, a retrospective study of 391 patients with COPD resulted in 25%
reporting experienced hypoxia-related symptoms during air travel with increased
symptom frequency in passengers with more severe baseline dyspnea (Dillard, Beninati,
& Berg, 1991).
The British Thoracic Society has recently issued new recommendations for
managing air passengers with stable respiratory disease (Ahmedzai et al., 2011). The
decision by the British Thoracic Society (BTS) to revise the recommendations for
passengers with respiratory disease traveling by air was based upon studies which
confirmed that neither resting sea level oxygen saturations nor forced expiratory volume
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in 1 second (FEV ) are reliable predictors of hypoxemia or complications associated with
air travel in patients with respiratory disease. Ahmedzai et al. (2011) determined that as a
result of the failure to predict response that there is no reliable threshold that can
accurately determine the safety of air travel or the need for in-flight oxygen in an
individual traveler with respiratory disease.
The 2011 recommendations by the BTS included review of guidelines currently
available from British, American, Canadian and European fitness to fly recommendations
and acknowledged that there were not consistent, practical nor comprehensive coverage
of recommendations for providers caring for patients with respiratory disease. As was
the case with their cardiology colleague’s recommendation for fitness to fly, Ahmedzai et
al. (2011) developed consensus recommendations rather than clinical practice guidelines.
The goals of the recommendations were to provide advice for respiratory specialists and
other health care providers who are involved in determination of passenger fitness to fly.
Ahmedzai et al. (2011) provided a thorough guide for managing patients with
stable respiratory disease planning air travel based upon the BTS recommendations. Key
points and recommendations from the guide for healthcare providers evaluating patients
with respiratory disease for fitness to fly include:
Cabin altitude may worsen hypoxemia in pulmonary disease and the physiologic
compensation for acute hypoxia is mild to moderate hyperventilation and
moderate tachycardia
FEV1 and SpO2 are useful markers of clinical severity in patients with respiratory
disease however, neither resting sea level SpO2 nor FEV1 appear to predict
hypoxemia or complications of respiratory disease associated with air travel.
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Healthcare providers evaluating a patient with respiratory disease for fitness to fly
should consider the patient’s prior flight experience, flight duration, destination
and time since last exacerbation of their respiratory condition.
Hypoxic challenge test (HCT) is not a test to determine fitness to fly but is
utilized to aid in the decision-making of whether a patient will require in-flight
oxygen
Patients with complex respiratory disease can be referred for hypobaric chamber
testing
The patient needs to take responsibility for the decision to fly and needs to
understand that the airline can refuse travel if the passenger’s health or safety is in
doubt at the time of presentation for travel.
BTS recommendations also include the statement that Respiratory physicians or
pediatricians should be the central referral point for consideration of safety to fly in all
cases. While this recommendation may be appropriate in the UK, the availability of
specialists for decision-making may not be practical in the U.S. and guidelines could be
evaluated by primary care providers with knowledge of flight physiology and patient
disease history.
Deep Vein Thrombosis
Venous stasis as a result of immobility in hospitalized patients has been
documented as a risk factor for the development of Deep vein thrombosis (DVT).
Passengers traveling for long distances who remained immobile have also been thought
to be at increased risk for DVT development and amongst all health conditions associated
with air travel is one with the most available studies (Scurr, Ahmad, Thavaraian, &
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Fisher, 2010). IATA (2011) fitness to fly guidelines for passengers with deep vein
thrombosis recommend evaluation by a health care professional for patients with active
DVT and clearance to fly for DVT patients who are asymptomatic.
DVTs result when there is a partial or complete blockage of the deep venous
system of the body by a blood clot, typically in the legs. Symptoms of DVT develop
gradually and diagnosis can be difficult. The signs and symptoms attributed to DVT may
include lower leg redness, a swollen or painful calf or thigh, increased skin temperature
in a change in coloration of skin over the affected area. Untreated DVT’s place a patient
at risk for developing pulmonary embolism which can result in death. Two longitudinal
cohort studies of ambulatory populations estimated 11% rate of 28-day mortality amongst
first episode venous thromboembolism (VTE) subjects (Chandra, Parisini, &
Mozaffarian, 2009).
In 1954, a 54-year-old doctor who had completed a 14 hour flight was the first
documented report of a DVT which developed as a result of venous thrombosis related to
air travel (Clarke, Hopewell, Juszczak, Eising, & Kjeldstrom, 2006). In 1977, the term
‘economy class syndrome’ was coined to describe DVTs which were thought to occur as
a result of prolonged sitting in the confined conditions associated with air travel (Clarke
et al., 2006). Several systematic reviews have been undertaken over the past decade to
attempt to definitively clarify the relationship between air travel and risk for venous
thromboembolism (MacCallum et al., 2011).
A 2002 systematic review of observational studies failed to conclude that there
was definitive evidence that air travel increase the risk of deep vein thrombosis (Clarke et
al., 2006). In 2007, another systemic review of 25 studies (6 case-control studies, 10
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cohort studies and 9 randomized controlled trials) was published with the end objective to
measure the methodological strength of the literature, estimate the risk of thrombosis
related to air travel, evaluate the efficacy of preventive treatments and develop evidencebased recommendations for practice (Philbrick, Shumate, Siadaty, & Becker, 2007).
The systematic review was once again unable to determine the risk of travel-related
venous thromboembolism because of three main weaknesses noted. The largest of the
cohort studies did not include routine screening for DVT but instead identified cases
through a retrospective medical record review. The authors found that retrospective
studies tended to report higher case counts attributable to the lack of limits on time or
setting (Philbrick et al., 2007). Routine screening in other case studies identified more
cases, mostly of asymptomatic DVTs, which would have erroneously been reported in a
retrospective study as related to travel.
There has been evidence suggesting that flights of eight hours or more may
increase the risk of deep vein thrombosis if a passenger has additional risk factors (Clarke
et al., 2006). Air travel-related risk factors for DVT include prolonged immobilization
and narrow economy class seats with limited legroom, dehydration, insufficient fluid
intake, and low humidity (Clarke et al., 2006). Additional risk factors related to
passenger’s personal health included hereditary or acquired clotting disorders, prior
history of DVT, older age, recent surgery or trauma, cancer, smoking, pregnancy, chronic
heart disease and obesity (Clarke et al., 2006).
A systematic review and meta-analysis of studies of travel and the risk for VTE
was published by Chandra, Parasini and Mozaffarian in 2009. The authors followed the
Meta-analysis of Observational Studies in Epidemiology (MOOSE) guidelines
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throughout the design, implementation and reporting of the meta-analysis. The study
selection identified 1560 abstracts via searches of MEDLINE, EMBASE, BIOSIS,
CINAHL, the Cochrane library, grey literature sources and a hand-search of the studies
identified in the reference lists of the selected abstracts. Of the 1560 abstracts identified,
1518 were excluded because they were commentaries, general reviews or case reports.
The remaining 42 studies were further examined and an additional 28 studies were
excluded because of study design issues such as lacking a non-traveling comparison
group, preventive measures for travel-related VTE and failure to meet the criteria for
VTE diagnosis.
The 14 selected studies in the meta-analysis included one prospective cohort
study (Schwarz et al., 2003), one retrospective cohort study (Kuipers et al., 2007), one
case-crossover study (Kelman et al., 2003), and eleven case-control studies (Chandra et
al., 2009). Pooled risk estimates for risk for VTE with travel were obtained by using
random-effects models with inverse-variance weighting.

The authors noted in their

analysis that due to the uncommon outcome of travel-related VTE they pooled together
the odds ratios from case-control studies approximate risk rations or relative risks from
cohort studies to generate one common relative risk.
The pooled relative risk for VTE among air travelers across the studies was 2.0
(95% CI, 1.5 to 2.7; p < 0.001) compared with non-travelers (Chandra et al., 2009).
Significant heterogeneity (P for Q statistic < 0.001) was noted and determined to occur in
the selection criteria for control participants in the case-control studies (P = 0.008).
When the authors classified the 14 included studies by use of referred control
participants, a case crossover design or a cohort they identified a statistically significant
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association between travel and VTE with an overall pooled estimate of 2.8 (CI, 2.2 to
3.7) as shown in Figure 14 (Chandra et al., 2009).
The pooled risk estimate for travel by air (RR, 2.2 (CI, 1.4 to 3.2)) was noted to
be higher but not statistically significant (P for heterogeneity = 0.140) than for travel by
surface means (RR, 1.14 (CI, 1.0 to 2.1)) (Chandra et al., 2009).
The meta-analysis of more than 4000 cases of VTE identified a 2-fold higher risk
for travelers compared to non-travelers. In case-control studies using individuals referred
for VTE evaluation as control participants there was no association found. The results of
the meta-analysis indicated that in non-referred control case studies, cohort or case-only
studies there was nearly a 3-fold higher risk for VTE in travelers leading the authors to a
conclusion that there was a higher risk for VTE associated with travel (Chandra et al.,
2009).
A dose-response relationship between duration of travel and risk of VTE was
identified by evaluation of 4 of the studies included in the meta-analysis where the data
was available for assessment (Figure 15). The authors observed an 18% higher risk for
VTE for each 2-hour increase in travel duration (Chandra et al., 2009).
Of the 14 original studies included in the meta-analysis, only 4 studies contained
the available data to assess risk associated with duration of travel and the resultant
confidence limits of the effect estimate are wide (4% to 33% higher risk) (Chandra et al.,
2009). Chandra et al. (2009) posit that the dose-response relationship appeared stronger
(26% higher risk/2 travel hours) amongst passengers traveling by air but had insufficient
data to compare direct pooled dose-response estimates for passengers travelling by air
versus surface travel modes. Regardless of the modality of travel, the dose-response
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analysis highlights the importance of preventive measures for VTE as duration of travel
increase.
The association between cumulative flight duration and risk of VTE was
evaluated further in a British community-based case-control study (MacCallum et al.,
2011). The authors sought to reduce bias by designing the selection of controls to include
subjects registered within the same general practice, same gender and closest in age to the
matched case in the practice register. As illustrated in Figure 16, cases were excluded if
the index events occurred outside of the pre-determined study entry, were not matched to
controls or did not have objectively confirmed VTE (MacCallum et al., 2011). Table 4
illustrates the characteristics of case and controls along with the univariate analysis of
risk factors. The MacCallum et al. (2011) results indicate that a cumulative flying time
of greater than 12 hours is associated with a similar risk of VTE within four weeks as
long-haul air travel
in which one or more flights is longer than 4 hours in duration.
An increased risk of VTE was associated with previous VTE, increased weight
and increased height (MacCallum et al., 2011). These findings were consistent with other
studies evaluating the risk factors associated with VTE (MacCallum et al., 2011). Recent
surgery was a significantly greater risk factor for VTE than air travel (MacCallum et al.,
2011). The risks associated with minor surgery were a similar order of magnitude to
those associated with long-haul air travel while the risk associated with major surgery
was one or two orders of magnitude greater than the risk associated with long-haul travel
(MacCallum et al., 2011).
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A 2010 Cochrane review exists for evaluation of compression stockings for
preventing deep vein thrombosis in airline passengers (Clarke, Hopewell, Juszczak,
Eising, & Kjeldstrom, 2006). The authors of the Cochrane review acknowledged the lack
of correlative evidence between air travel and DVT but posited that due to the low
incidence of deep vein thrombosis in the general population it is unlikely that studies with
adequate sample sizes to detect slight increases in risk will ever be conducted (Clarke et
al., 2006). The Cochrane review focused not on determining the correlation between air
travel and DVT development but rather the effectiveness of wearing compression
stockings in the prevention of DVT in passengers traveling for long distances.
Randomized trials that compared passengers wearing compression stockings against
passengers not wearing them during long-haul flights were included in the analysis. The
primary outcome evaluated was the diagnosis of symptomatic or symptomless DVT
(diagnosed by ultrasound, venogram or isotope). Secondary outcome measures evaluated
included diagnosis of pulmonary embolism, death, superficial venous thrombosis, edema,
and adverse effects as a result of the use of compression stockings.
A 2012 executive summary published by the American College of Chest
Physicians (ACCP) reviewed the current recommendations associated with prevention of
thrombosis in traveling patients in an effort to establish an evidence-based clinical
practice guideline for antithrombotic therapy and thrombosis prevention (Guyatt, Akl,
Crowther, Gutterman, & Schunemann, 2012). The ACCP reviewed available literature
and graded the current recommendations for long-distance travelers at risk of VTE. At
risk travelers were identified in the guideline as those who had previous VTE, recent
surgery or trauma, active malignancy, pregnancy, estrogen use, advanced age, limited
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mobility, severe obesity or known thrombophilic disorders (Kahn et al., 2012). The
result of their evidence-based review included the following recommendations for
prevention of VTE in non-surgical patients traveling long-distance:
frequent ambulation, calf muscle exercises or sitting in an aisle seat if feasible
during travel the use of properly fitted, below-knee graduated compression
stockings (GCS) which provide 15-30 mm HG of pressure at the ankle
In addition to the recommendations above, the guidelines advice against the use of GCS
by long-distance travelers not meeting the conditions listed as at increased risk of VTE
and avoidance of the use of aspirin or other anticoagulants to prevent VTE in longdistance travelers (Kahn et al., 2012).
The recommendations by the ACCP in their 2012 supplement were analyzed
using GRADE criteria. Each of the recommendations received a Grade 2C rating
identifying the recommendation as having a questionable benefit/risk and having been
derived from a low quality of evidence (Guyatt et al., 2006). The 2012 ACCP
recommendations include a further downgrading from the 8th edition of ACCP clinical
practice guidelines which listed calf muscle contraction as an ACCP grade 1C
recommendation and aspirin therapy as an ACCP grade 1B recommendation (Gerts et al.,
2008). The ACCP published a disclaimer to their 2012 guidelines related to their
recommendations requesting that caution be exercised in performance measure
development and public reporting of guideline recommendations graded in the 1C, 2 A,
2B and 2C category according to the ACCP Grading System (Guyatt et al., 2012).

The

ACCP recommendations could be subject to future revision based upon the findings of
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the World Health Organization Research into Global Hazards of Travel (WRIGHT)
Project’s phase 2 publication (WHO, 2007).
Blood Disorders
The recommendations associated with assessment of fitness to fly for passengers
with anemic disorders are based upon the principles of the effect of flight physiology on
the hematologic system. No recent research studies were found evaluating the
parameters of fitness to fly and current guideline recommendations appear to be based
upon experience and recommendations of the sponsoring organizations.
The ASMA (2002) recommendations establishing hemoglobin levels for concern
at less than 8.0 gm/dl are due to potential for passenger lightheadedness or potential for
loss of consciousness during flight especially when associated with ambulation to the
bathroom or physical activity during flight (ASMA, 2003). Recommendation for oxygen
in patients experiencing sickle cell crisis was made to avoid potential life-threatening
sequela that may be induced as a result of the combination of sickle cell crisis and the
hypobaric hypoxic environment induced with flight. Per the ASMA (2002), sickle cell
trait has not been associated with health problems at cruising altitude. Recommendations
for travel without use of supplemental oxygen in-flight ranged from 7.5 g/dl to the IATA
recommendation of 9.5 g/dl (UK Civil Aviation Authority, 2007; Patel & Simon, 2010;
DeHart, 2003; International Civil Aviation Organization and International Air Transport
Association [ICAO & IATA], 2005) by publication regarding the absolute hemoglobin
level. While the recommendations appear to be prudent, no record of basis for
determination of hemoglobin levels by evidence-based guidelines could be located in any
of the available research.
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Central Nervous System Disorders
The recommendations associated with assessment of fitness to fly for passengers
with central nervous system disorders are based upon the principles of the effect of flight
physiology on the central nervous system. No recent research studies were found
evaluating the parameters of fitness to fly and current guideline recommendations appear
to be based upon experience and recommendations of the sponsoring organizations.
General recommendations found by literature search, while lacking in reference source
information, were consistent with the IATA (2011) recommendations are included in
ASMA (2003) guidelines caution patients with epilepsy to refrain from consuming
alcohol before or during air travel and note that epileptic patients should be informed of
the potential seizure threshold-lowering effects of fatigue, delayed meals, hypoxia and
circadian rhythm disruption associated with long-distance travel.
Seth, Mir, Dhir, Cheeseman & Singh (2009) addressed evaluation of fitness to fly
post craniotomy. The authors found sparse and contradictory data related to intercranial
pressure changes (ICP) associated with cabin altitude and noted that there are no wellconducted studies available that demonstrate the effect of long distance air travel on post
craniotomy patients (Seth, Mir, Dhir, Cheeseman, & Singh, 2009).
Sirven et al. (2002) evaluated a total of 2,042 medical incidents that were reported
to the Mayo Clinic Department of Emergency Medicine and Medical Transportation
Service that resulted in 312 flight diversions. Neurologic symptoms were the largest
category of medical incidents (31%) resulting in 626 air-to-ground medical calls to the
clinics (Sirven et al., 2002). Dizziness/vertigo was the most common report neurologic
symptom (Table 8) followed by seizures, headaches, pain, and cerebrovascular
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symptoms yet the most common cause for flight diversion were seizures. It was
hypothesized that the increased incidence of diversion was likely due to the “dramatic
presentations” which led to an immediate call for crew attention (Sirven et al., 2002, p.
3).
A prospective analysis of patients with neurologic symptoms referred from the
Madrid-Barajas International Airport to the emergency department at the Hospital
Universitario Ramon y Cajal for neurologic consultation resulted in the evaluation of 77
patients over a 21 month period from May 2008 to January 2010 (Alonso-Canovas et al.,
2011). Of the 77 cases identified, seizures were the cause for consultation for 39
(50.6%), Stroke 18 (23.4%) and the remaining 20 (26%) were attributed to other causes.
Twenty-five (61%) of the seizure patients identified had no prior history of seizure.
Classification of causes of identified seizures included idiopathic (20/48/8%), acute
symptomatic or provoked as a result of missed doses of antiepileptic medication or
drugs/alcohol contributed to 39% of the remaining subjects. Recreational drug use (p=
0.0008) and past history of seizures (p = 0.0007) were significantly associated with
referral for seizure activity in flight (Alonso-Canovas et al., 2011). Eighteen patients
referred for stroke (23.4%) of which 14 reported vascular risk factors including
hypertension, tobacco use, cardiopathy, hypercholesterolemia and diabetes mellitus.
Vascular risk factors were significantly associated with stroke (p = 0.0017). AlonsoCanovas et al. (2011) suggested that air travel may be a factor for induction of neurologic
problems while noting that the study was limited by a lack of information related to the
flight diversion or treatment applied in-flight. Additionally, in patients diagnosed as
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having a stroke, 1/3 were noted in post diagnostic evaluation to have carotid stenosis
(over 50% occlusion) which likely was a significant contributor to stroke etiology.
Airplane headache has been reported as a new type of headache with specific
symptoms temporarily related to air travel (Alonso-Canovas et al., 2011; Berilgen &
Mungen, 2011). The characteristics of airplane headache are a headache that starts
suddenly during aircraft ascent and/or descent. The headache associated with air travel is
typically severe, stabbing, unilateral, most often localized to the periorbital region and
has a mean duration of 20 minutes subsiding shortly after landing (Berilgen & Mungen,
2011; Evans, Purdy, & Goodman, 2007; Berilgen & Mungen, 2006). Thirty-three cases
(28 male, 5 female) of suspected headache associated with air travel were identified
Berilgen and Mungen (2011). The case study headaches were not associated with other
migraine history or symptoms and of those 33 cases, 22 were evaluated by a neurologist
and found to be normal. Berilgen and Mungen (2011) analyzed the cases and
hypothesize that the headache associated with air trauma is likely due to temporary sinus
barotraumas or local inflammation in the sinus area as a result of hypoxia or reduced
cabin humidity. Of note is that of the patients evaluated, 95% of the identified cases did
not have recurrent headache symptoms in subsequent flights when premedicated one hour
before take off with 550mg of naproxen sodium. A separate self-reported case study of
what was considered to be airplane headache also responded positively to premedication
with naproxen (Marchioretto, Mainardi, & Zanchin, 2008).
Eye, Ear, Nose and Throat
The recommendations associated with assessment of fitness to fly for passengers
with ear, nose and throat (ENT) disorders are based upon the principles of the effect of
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flight physiology on the ENT system. The recommendations associated with assessment
of fitness to fly for passengers with ophthalmologic disorders are based upon the
principles of the effect of flight physiology on the ophthalmologic system. In-flight
evaluation of intraocular pressure (IOP) change in healthy subjects during air travel was
examined by Bayer et al., 2008. Twenty-five healthy volunteers underwent evaluation of
IOP for change from ground level measurement, at cabin pressures of 8000 feet and post
landing in an attempt to determine the effect of air travel on the IOP of healthy subjects
(Bayer et al., 2008). Total flight duration was 2 hours and 55 minutes and repeated
ANOVA test was used for IOP value comparison between the consecutive measurements
with p values of 0.05 considered to be significant. A significant decrease in IOP was
noted on the second hour of flight (13.4%, p = 0.005) and after landing (15.7%, p =
0.001). Bayer at al. (2008) were unable to determine the length of time post landing that
the decrease in IOP persisted as no further measurements post landing were performed.
Conclusions were drawn from hypobaric chamber studies which demonstrated a return to
normal of IOP 2-5 hours after exposure to high altitude simulation (Bayer et al., 2008).
The Bayer et al. (2008) study offers initial information related to the effects of air travel
on IOP, the study is limited by the small sample size and does not offer information
related to the effects of long-haul travel or the duration of IOP decrease post landing.
The statistical significance of the study would support further investigation.
Exposure to allergens in flight is of particular concern for patients who have
severe allergic reactions such as anaphlyaxis or exacerbation of asthma after exposure to
irritants. The consequences of a severe allergic reaction mid-flight without appropriate
medical assistance can be life-threatening. One in ten individuals is known to have
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allergies to animals but few consider the potential for exposure that may occur in animals
brought onboard the aircraft by other passengers. Exposure to dander cannot be avoided
by restricting seating away from animals within the cabin because of capacity filled
flights as well as the persistence of dander even after a passenger with a pet has deplaned.
Stanbrook, Kovesi and Hebert (2010) reported that one study found clinically significant
cat dander concentrations have been noted on 100% of sampled domestic airline seats
and 16% of seats on international flights. As of 2010, the Canadian Transportation
Agency began examining pet policies on commercial aircraft carriers to evaluate whether
the admission of animals within aircraft cabins could pose a threat to the health and wellbeing of some passengers (Kondro, 2010).
Several airlines have ceased to serve peanuts following reported anaphylactic
reactions in passengers who inhaled peanut dust (Stanbrook, Kovesi, & Hebert, 2010).
While the removal of peanut, nut and seed products by airlines reduces the risk of
exposure to passengers, the ability and commonplace occurrence of other passengers on
an aircraft bringing food sources or items with peanut, nut or seed dust on them cannot be
regulated by the airlines. To assist at-risk passengers, the IATA (2011) recommends that
passengers with severe allergies plan ahead by contacting their physician, discussing
travel related risks and obtaining the prescription of an epinephrine auto-injector or other
allergy medicine to be carried onboard for use as needed.
Trauma
The recommendations associated with assessment of fitness to fly for passengers
with trauma are based upon the principles disease management as well as the effect of
flight physiology. Key flight physiologic considerations for the healthcare provider to
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consider when evaluating a post-surgical or post-trauma passenger for fitness to fly
include:
Passengers in this category are at risk for increased oxygen consumption as a
result of trauma or surgery. Supplemental oxygen may be considered if the
patient is anemic, volume depleted or known to have concomitant
cardiopulmonary disease which may be further compromised by the hypoxic
conditions of flight (ASMA, 2003).
Intestinal gas will expand 25% by volume at a cabin altitude of 8000 feet and
patients who are post-abdominal surgery may be at risk for bleeding, perforation
or tearing at suture sites as a result of increased pressure, stretching gastric or
intestinal mucosa (ASMA, 2003).
Patients with bowel obstruction as well as post colonoscopy may not be able to
accommodate the additional gastrointestinal gas expansion during flight (ASMA,
2003).
Neurosurgical and passengers post ophthalmologic surgery may be subject to
trapped gas which will cause increased pressure in flight (ASMA, 2003).
No recent research studies were found evaluating the parameters of fitness to fly
and current guideline recommendations appear to be based upon experience and
recommendations of the sponsoring organizations.
Pregnancy
There are various air travel restrictions placed upon pregnant passengers by both
domestic and international airlines which vary by airline. Yet, there is no clinical
practice guideline nor formal clinical evidence exists that provides an absolute
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contraindication to travel for pregnant women (Hezelgrave, Whitty, Shennan, &
Chappell, 2011). The decision upon whether to provide fitness to fly for a pregnant
traveler is made on an individual basis by the passenger’s healthcare provider and is
dependent upon gestational age, the degree of clinical compromise and the presence of
pre-existing comorbid conditions (Hezelgrave et al., 2011). The basis of concern for
most airlines to restrict air travel for pregnant women is to avoid the undesirable
consequence of flight diversion or delivery in flight where they may be a lack of
appropriate facilities or care providers to manage labor and pregnancy complications
(Royal College of Obstetricians and Gynaecologists [RCOG], 2008; UK Civil Aviation
Authority, 2007). The American College of Obstetricians and Gynecologists issued a
committee opinion on obstetric practice in 2009 in which they posited that in the absence
of medical or obstetrical complications that air travel is safe for pregnant women
(American College of Obstetricians and Gynecologists [ACOG], 2009).
Not surprisingly, there is a paucity of research available on air travel during
pregnancy and recommendations by obstetric sources are made based upon the scientific
knowledge related to the physiology of flight and the physiologic changes of pregnancy.
Hezelgrave, Whittey, Shennan and Chappell (2011) note that while most pregnant
women are low risk pregnancy and can be expected to travel without any complications,
there are additional risks that should be considered during each trimester which can be
further complicated by comorbid medical conditions.
A search of the literature resulted in two research studies which directly addressed
the issue of passenger air travel and pregnancy outcomes. A retrospective analysis of 992
healthy pregnant women with single pregnancies of gestational ages of 20 weeks or
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greater admitted for delivery over a 12-month period between May 2003 and May 2004
was performed to analyze whether there was an elevated risk of adverse pregnancy
outcomes associated with air travel (Chibber, Al-Sibai, & Qahtani, 2006). The study was
performed in the antenatal clinics of a Saudi Arabian university teaching hospital
designated as tertiary care centers. The study group consisted of pregnant women who
had travelled by air at least once during their pregnancy and the control group were those
who did not travel. Study group members were asked to provide gestational age,
destination, length of flight and any complications during travel. Chart review by an
investigator blinded to the travel status of the participants was performed to obtain
medical history, obstetric complications and pregnancy outcome information.
Women with any pre-pregnancy medical complications, vaginal bleeding, history
of tocolysis administration for preterm labor, fetal anomalies, neonatal structural
anomalies or chromosomal anomalies were excluded from the study. The study group
consisted of 546 women who travelled at least once during their pregnancy of which 312
(57%) were primiparous, and 234 (43%) multiparous. The study group flew for the first
time during pregnancy at a gestation age of 11.2 +/- weeks with average flight times
lasting 7.8 +/- 1.2 hours and a median of 7 flights (range 1-18). There was a statistically
significant incidence of expatriates among the travel group over Saudi nationals (see
Table 15). The control group consisted of 447 pregnant women of which 241(54%) were
primiparous and 206 (46%) were multiparous.
Amongst primiparous passengers, air travel during pregnancy was associated with
an increased risk of preterm birth at <37 and > 34 week gestation (OR 1.5; 95% CI 1.2,
1.8, see Table 16). Regression analysis demonstrated a relationship between gestational
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age at delivery and gestational age at first air travel (r = 0.002, P = 0.01) and total hours
of flight (r = 0.012, P = 0.01) of which the risk factor associated for preterm delivery
persisted when evaluated on the whole group analysis of data . When adjustments were
made for age, socioeconomic status there was a decrease in magnitude of the association
between travel and preterm primiparous delivery but the association remained statistically
significant (Chibber et al., 2006). While the birthweights of the preterm infants were
lower than controls, no statistically significant increased risk of admission to the neonatal
intensive care unit was noted suggesting that these infants were not at any greater risk
than the controls for respiratory distress or intraventricular hemorrhage associated with
preterm delivery.
Several confounding variables existed in the study which may have contributed to
bias in the results. There was a significant racial difference amongst the women who
travelled and those who did not which Chibber at al. (2006) acknowledge correlates with
cultural and lifestyle choices of foreigners in Saudi Arabia who may be more likely to
travel during months of greater heat or who may choose to travel because they are
challenged by the local customs and find the lifestyle and dress codes restrictive. The
failure of the authors to assess tobacco use and alcohol consumption was another
potentially significant confounding variable in the study as both substances are known to
be associated with preterm delivery and lower birth weight. In the absence of this data,
the results, despite appropriate statistical analysis of the data, may be biased.
A strength of the Chibber et al. (2006) study was the ability to accurately assess
gestational age of the women studied. Additionally, the study had a larger sample size
than prior research evaluating the effect of air travel and pregnancy outcomes.
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A whole group analysis was performed and it was determined from the findings
that air travel during pregnancy was associated with an increased risk of preterm births at
< 37 and > 34 weeks gestation (Chibber et al., 2006). Gestational age at delivery
correlated with lower birthweight among the women. No differences or risk elevations
were found between pregnant air travelers and non-air travelers in the rates of other
evaluated sequel.
The second study located by literature search was a 6-month questionnaire of
women admitted to Georgetown University Medical Center in Washington D.C. with
impending delivery while at least one of the author’s of the study was on call (Freeman et
al., 2004). The study population accounted for 13% of the deliveries in the facility during
the study period.
Exclusion criteria included fetal anomalies, neonatal structural or chromosomal
anomalies (n= 3). Medical history obstetric complications and pregnancy outcomes were
obtained by a chart review blinded to air travel status. Variables collected on the study
population included maternal age and race, parity, history of adverse pregnancy outcome,
presence of pre-pregnancy complications, medications during pregnancy, initial
hematocrit at first prenatal visit and hematocrit at the time of delivery (Freeman et al.,
2004). Adverse pregnancy outcomes were evaluated using a composite analysis of
stillbirth, Apgar score at 5-minutes, preterm delivery <37 weeks, preeclampsia and birth
weight and the between group prevalence (Table 19). Logistic regression analysis was
performed to account for the significant differences in racial distribution between the
groups.
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Limitations of the Freeman et al. (2004) study included the sample size as well as
the convenience sampling criteria associated with investigator availability. Power
analysis performed by the Freeman et al. (2004) found that a sample size of 2,803 women
per group would be needed in order to demonstrate that air travel has a protective effect
against adverse pregnancy outcome (alpha = 0.05, beta = 0.80). The sample studied was
substantially smaller and to date there are no studies performed with sample sizes of
pregnant travelers that large.
Another potential for bias and study limitation was that the questionnaire was
administered by the authors and it is therefore subject to recall reliability and failure to
disclose information may have impacted the results as well as selection bias. The authors
note that women admitted in preterm labor or experiencing pregnancy complications
generally manifest a over-recall rather than an under-recall of potential causative factors
(Freeman et al., 2004). The bias related to recall may still exist in this study as it was a
convenience sample that included both women presenting to deliver without
complications as well as those who may be delivering preterm or with complications.
Racial differences, as noted previously, was another potential confounding
variable in the study and the authors noted in the study that the higher rate of Caucasian
women who traveled may reflect a sociodemographic difference between the two groups
and may also be reflective of the higher hematocrit in air travelers since they were
predominantly Caucasian which is a race known to normally have higher hematocrit
levels than other races (Freeman et al., 2004).

No significant association between air

travel and composite adverse pregnancy outcomes were found when a logistic regression
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analysis was performed taking into account race as well as other demographic variables
(Freeman et al., 2004).
A literature search was published in 2010 which aimed at evaluating the
relationship of air travel and spontaneous abortion, intrauterine fetal demise (IUFD), low
birth weight (<10th percentile), preterm delivery and neonatal intensive care unit
admissions (Magann et al., 2010). The literature search identified 128 publications of
which 9 abstracts evaluated air travel and pregnancy outcomes. The Chibber et al. (2009)
and Freeman et al. (2004) studies addressed previously was the only two studies of the
nine which specifically evaluated the outcomes in traveling passengers and not flight
attendants and/or aviators. Flight attendants and aviators were excluded from our review
based upon the concept that their health, risk factors, flight times and number of flights
differ significantly from the average travelling passenger. Regardless, with the inclusion
of the flight attendants and aviators in their review, Magann et al. (2010) were unable to
identify an increased risk of neonatal intensive care unit admissions (OR: 1.19, 95% CI:
0.74, 1.82), low birth weight (OR: 1.25, 95% CI: 0.62, 2.48) or pre-eclampsia (OR: 0.86,
95% CI: 0.58, 1.27) when subjects were compared to controls. The risk of pregnancy
loss (spontaneous abortion or IUFD) was greater in flight attendants than controls (OR:
1.62, 95% confidence interval: 1.29, 2.04) but none of these studies evaluated pregnant
passengers versus controls so a generalization may not be valid given the increased risk
factors of flight time exposure amongst flight attendants (Magann et al., 2010). No
similar increased risk of pregnancy loss was found in either the Chibber et al. (2009) or
the Freeman et al. (2004). Results of the Chibber et al. (2009) study indicating an
associated increased risk of preterm birth (<37 weeks) was reported by the authors.
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Magann et al. (2010) noted that the correlation between air travel on pregnancy outcomes
has been poorly studied and the inadequacy and lack of data on air travel an pregnancy
outcomes makes an evidence-based recommendation impossible to provide.
Psychological Disorders
It is estimated that fear of flying affects 10-40% of the commercial air
traveling population (Van Gerwen, Spinhoven, & Van Dyck, 2006). Symptoms
associated with flight related anxiety range from mild anxiety to pathological fear. Air
rage is described as disruptive behavior associated with air travel and is thought to be
associated with travel related stress and exacerbated by alcohol ([WHO], 2011).
Matsumoto and Goebert (2001) retrospectively reviewed 1375 physician consultation
calls in 1997 to a 24 hours medical consultation service that provided coverage to 9
commercial domestic and international airlines and found that 3.5% of all medical inflight emergencies fell under the category of mental disorders. Of the consultations
provided in the Matsumoto and Goebert study, 90% were had anxiety as their primary
symptom and 4% psychosis. Avoidance behavior, behavior and cognitive therapy and
anxiolytic medications may be means by which transient anxiety and stress associated
with air travel can be controlled and therefore fear of flying is not considered to be a
condition that would warrant a fitness to fly examination (Bogaerde & De Raedt, 2008;
Van Gerwen, Spinhoven, & Van Dyck, 2006; Waterhouse, Reilly, & Edwards, 2004).
Concern exists that the stress associated with traveling to and within a busy
airport terminal as well as the physiologic changes of flight and environmental conditions
within the aircraft cabin may lead to exacerbation on underlying psychiatric conditions or
decompensation of previously stable conditions (DeHart, 2003). Jet lag and disruption of
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the circadian rhythm is also thought to be a contributory factor for the potential
exacerbation of psychotic conditions (Katz, 2011). While conditions leading to
exacerbations of psychiatric disorders are temporary and not likely to lead to long-term
problems with the passenger’s health, concern for the ability of the crew to safely
conduct a flight may require prior medical clearance for passengers exhibiting psychiatric
symptoms of concern to air or ground crew. Passengers who are aggressive,
unpredictable, disruptive, disorganized or unsafe may trigger airline personnel to request
further evaluation which prohibits the passenger from flying (ASMA, 2003). Most
guideline recommendations for fitness to fly related to psychotic patients recommend that
travel be accompanied by a trained medical escort or other individual who can ensure
psychiatric medication management and assist with control of the affected passenger
when needed (Patel & Simon, 2010; UK Civil Aviation Authority, 2007).
Diabetes
Evaluation of the effects of air travel on patients with diabetes is an emerging area
of comorbidity that has only recently begun to be evaluated in terms of flight related
physiology. A study of the effects of atmospheric pressure on insulin pump delivery
during flight identified unintended insulin delivery in pumps by bubble formation and
expansion of bubbles (King, Goss, Paterson, Crock, & Anderson, 2011). King, et al.
(2011) evaluated the effect of ambient pressure during simulated flight in hypobaric
chambers mimicking ascent, descent and catastrophic depressurization on insulin pump
delivery, bubble formation, bubble size and cartridge plunger movement in ten insulin
pumps connected to capillary tubes. A Student t test of the results found that excess
insulin delivery of 0.623% of the cartridge volume occurred (p < 0.001) in both types of
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pumps evaluated (Animas and Medtronic). No statistical difference was noted between
pump types when abnormal insulin delivery was evaluated as a percentage of insulin
volume (King et al., 2011). While this study was not performed on diabetic patients with
insulin pumps in place, it does raise the question of whether or not there may be
unintentional hypoglycemia that results during air travel for passengers with insulin
pumps. Unintentional hypoglycemia in combination with travel fatigue, jet lag, limited
food availability in flight can result in serious consequences if not monitored
(Waterhouse, Kao, Edwards, Atkinson, & Reilly, 2006).
Miscellaneous Conditions
The recommendations associated with assessment of fitness to fly for passengers
with communicable disease, terminal illness and decompression syndrome are based
upon the principles disease management as well as the effect of flight physiology.
Despite concerns associated with spread of infection in aircraft cabins, there is very little
risk of infectious disease transmission on board of commercial aircraft (WHO, 2011).
Transmission of infection may occur between passengers in close contact related to
seating areas but the aircraft ventilation system utilized in commercial aircraft is similar
to that found in hospital surgical suites and intensive care units. HEPA filter systems
help reduce transmission of particles, bacteria, fungi and viruses during recirculation
exchange and the rate of disease transmission onboard an aircraft is no more likely than
that which would occur for the same passenger in a commercial building (WHO, 2011).
Recommendations to avoid travel until passengers with infectious disease are beyond the
period of contagion are the same as would be offered for the patient avoidance of public
areas to reduce the spread of disease.
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CHAPTER 3
Conceptual Framework
The ACE Star Model of Knowledge Transformation (ACE) is the conceptual
framework chosen for this capstone project as it is a model which allows for the
transformation of knowledge and integration it into evidence based practice (EBP)
(Kirchhoff, 2008). The ACE model is based upon a five point star (Appendix C) that
depicts the stages of knowledge transformation (Stevens, 2004). The model stages
include discovery, summary, translation, integration and evaluation. In the ACE model
evidence translation is developed as each stage of transformation is a building block for
the previous stage resulting in newly discovered knowledge being implemented into
practice (Kirchhoff, 2008).
Discovery is the first star point of the ACE model (Stevens, 2004). The discovery
stage involves knowledge generated through the conduction of quantitative and
qualitative primary research studies. The evidence generated from these primary studies
is utilized to develop clinical decisions (Stevens, 2004).
Evidence summary, the second star point, generates knowledge through the
development of a summary of available research into statements to guide practice. A
systemic approach is utilized to reduce bias and provide for reliability of the evidence
(Stevens, 2004). Systematic reviews, evidence summaries, review of the literature and
meta-analyses are examples of evidence summaries (Stevens, 2004).
The third star point, translation, involves the summary of evidence into standards
of practice or clinical practice guidelines (CPG). CPGs provide a means for healthcare
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providers, patients and organizations to make informed clinical decisions and provide for
standardization of clinical practice (Stevens, 2004).
Integration, the fourth star point, is the stage at which CPGs are implemented into
practice. Practice integration of evidence occurs at individual and/or organizational
levels with the goal of the stage being the adoption of recommendations into routine
practice (Stevens, 2004; Kirchhoff, 2008).
Evaluation is the fifth star point of the ACE process. The assessment of the effect
of the utilization of the CPG on patient outcomes, patient satisfaction ratings, system
efficiency, and cost analysis are methods by which the evaluation stage leads to
continued improvement in clinical practice (Stevens, 2004).
The proposed capstone project will focus on the development of a CPG for
primary care providers to be able to utilize in their daily practice. The capstone project
will focus predominantly on the evaluation and integration stages of the ACE Star Model.
The CPG developed will provide an evidenced-based guideline for integration into
primary care practice.
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CHAPTER 4
Methodology
Evidence-based Project Plan
The intent of the capstone project was to perform an evidence-based systematic
review and synthesis for the purpose of the development of a clinical practice guideline
(CPG). Literature from was obtained by internet and electronic database searches of
published evidence via Medline, PubMed, the Cochrane Library CINAHL (EBSCOHost),
and other electronic sources for admissible evidence or studies published between
February 2001 and February 2012. Search terms included air, plane, aircraft, travel,
airline, fitness to fly, commercial air, hypoxia, hypoxemia, pre-flight, post-flight,
cardiovascular, circulatory, blood, hematology, anemia, pulmonary, COPD, respiratory,
asthma, restrictive lung, non-restrictive lung, neurologic, neurology, central nervous
system, gastrointestinal, abdomen, ear, nose, throat, psychiatric, anxiety, psychosis, eye,
ophthalmologic, pregnancy, children, pediatric, orthopedic, surgical, surgery, trauma,
disease, infection, pain, and prevention. Identified studies were limited to those written
in English or with available English translations. Expert opinion and guidelines
developed by other sources were included in the guideline development and all efforts
were be made to correlate opinion and published guidelines to primary sources of
research.

Patient outcomes of interest were identified and the GRADE approach (Appendix D)
was utilized to assess the magnitude of effect of recommendations and quality of
evidence. Categories of evaluation for the capstone project followed the areas of the
IATA medical group recommendations related to passenger fitness for air travel:
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cardiovascular disease, blood disorders, pulmonary disorders, central nervous system
disorders, gastrointestinal disorders, ear/nose/throat disorders, psychiatric illness,
ophthalmologic disorders, pregnancy, trauma and miscellaneous conditions.

Resources Required
No funding was required for completion of the capstone project. The primary
resource requirement was the investigator’s time to perform the search for studies, grade
the reviews and synthesize the data into an evidenced-based practice guideline. There
was no cost associated with the review of the guideline by the clinical content
professionals.

Minimal costs were associated with printing necessary for project

completion and were covered by the project author.

IRB Approval
The project was submitted to the University of Nevada Las Vegas Office of
Research Integrity for IRB approval for exempted research consideration based upon the
criteria as being a collection or study of publicly available data that does not involve
human subjects or individual subject identifiers. On October 18, 2011 the protocol was
reviewed by the University of Nevada Las Vegas Office of Research Integrity – Human
Subjects and was deemed excluded from IRB review (Appendix E).
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CHAPTER 5
Results
A comprehensive systematic review of the literature was performed and current
knowledge in the form of expert opinion and published guidelines was incorporated into
the final clinical practice guideline. The CPG developed graded the applicable data
according to both the quality of available evidence and the strength of the
recommendations. The CPG was developed in the format accepted by the Agency for
Healthcare Research and Quality and is included in this paper as Appendix G.
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CHAPTER 6
Summary, Conclusions and Recommendations
After an exhaustive review of the literature it became evident that although
published research existed on fitness to fly guidelines for a variety of health related
issues, there were few direct clinical evidence studies of the pathophysiologic effects of
commercial airline travel on passengers with pre-existing diseases. The majority of
published research and fitness to fly guidelines were developed by applying the principles
of the effects of flight on physiologic systems, based upon research conducted in hypoxic
simulated laboratory environments, developed from studies performed on subjects
adapting to altitude on land, or formulated as opinion by expert individuals or working
groups. Attempts to apply the grade approach to the research resulted in downgrading of
evidence recommendations in the developed guidelines due to the small sample sizes,
lack of study randomization and blinding, failure to control for bias and other designrelated issues that affected the research reliability. The majority of the available research
anecdotal clinical case studies and expert opinion and therefore fell under the category of
very low quality of strength of recommendation.
Shurlock (2010) acknowledged the lack of clinical data available to make
appropriate guidelines for fitness to fly. Instead of focusing on diseases, per se, the
Working Group of the British Cardiovascular Society (Smith et al., 2010) focused on the
cabin environment and stratifications of levels of risk. The final published report of the
Working Group acknowledges that here are few direct clinical studies of the
pathophysiological effects of air travel on patients with existing diseases and therefore
their guideline advice was based on the physics and physiology of the aircraft cabin
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environment and its potential impact on patients with pre-existing conditions.
Ultimately, the British Cardiovascular Society working group gave their
recommendations based upon their expert knowledge because of the lack of randomized
controlled trials available to meet the criteria of a clinical practice guideline. The aim of
the guidelines, according to Smith et al. (2010), was not to be restrictive but to allow
passengers to fly. Smith et al. (2010) also acknowledged that the lack of randomized
controlled trials, meta-analysis and registries regarding the effect or risks of air travel
upon patients with cardiovascular disease prevented them from developing clinical
practice guidelines. As a result, the working group chose to review available evidence
and then apply clinical professional judgment in conjunction with present knowledge of
the physiological effects of the aircraft environment on the pathophysiology of
cardiovascular disease as had other expert panels addressing the issues associated with
fitness to fly.
The currently available clinical guidelines for establishing fitness to fly produced
by disease-specific specialty group sources such as ASMA (2003), IATA (2011), the UK
Civil Aviation Authority (2009), the British Thoracic Society (Ahmedzai et al., 2011), the
British Cardiovascular Society (Smith et al., 2010) and ACOG (2009) provide similar
recommendations related to passenger disease or pre-existing condition and the need for
evaluation prior to travel. Their recommendations are also based predominantly on case
study reports, expert opinion, simulated environment research studies and small studies
with limitations in quality outcome measures. A review of the updated BTS fitness to
fly guidelines suggested that based on the “lack of clarity” in the available advice,
inadequate data for classification of in-flight events and “anachronistic advice that did not
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consider levels of risk” it would be best to not develop fitness to fly guidelines but rather
to determine which patient should be cleared to fly on the basis of the risk of a
spontaneous event in an aircraft cabin environment with limited available emergency
treatment (Shurlock, 2011, p. 1045).
There is validity associated with concerns related to guidelines that are not
supported by evidence-based research and it can be argued that no evidence-based
clinical practice guideline could be developed for commercial airline passenger fitness to
fly due to the lack of quality clinical research findings. Few of the available published
studies evaluated for this capstone project exceeded the GRADE guideline for low
quality research because of the lack of the reliance on case reports, consensus opinion
and contradictory small studies with limitations lowering the strength of the results.
Regardless, evidence-based analysis can be applied and the guideline presented as a
result of this capstone project can be implemented as a resource to guide primary care
professional screening, decision-making and preventive care based upon currently
available information.
The field of travel medicine is a new and emergency specialty area and
recommendations for further evaluation include improving undergraduate and
postgraduate travel medicine education, adding travel history to initial health history
forms, development of instruction sheets for dissemination to primary care providers,
airlines and the traveling public as well as performing larger, higher quality research
studies to clinically evaluate travel related health issues (Talbot, Chen, Sanford,
McCarthy, & Leder, 2010; Ruis, Van Rijckevorsel, Van den Hoek, Koeman, & Sonder,
2009; Van De Winkel, Van den Daele, Van Gompel, & Van den Ende, 2007). The
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research, expert opinion and published guidelines identified in this study focused on
individual issues or health problems and the paucity of studies in each of the IATA
identified areas warrants further investigation to validate recommendations. Several
areas of future research and opportunity were identified during the review of the
evidence.
One means of improving the reliability of information and data gathering would
be for the implementation of an international registry to document in-flight medical
emergencies. Accuracy of data collected related to in-flight medical events would be
improved significantly if standardized reporting requirements and terminology were
implemented as part of the registry process. Data collected from an international
database with standardized categories could be used to identify actual incidences of
health related occurrences and provide direction for further epidemiologic research.
International flight related medical occurrence data could be utilized to adapt and
standardize the contents of the onboard medical kits to meet the actual identified needs of
in-flight health issues. Extrapolated epidemiologic data could also be utilized to develop
preventive health information and improved pre-flight screening strategies for healthcare
providers. Future recommendations and research should include patients with comorbid
conditions to evaluate the potential for cumulative negative effects.
Hypobaric hypoxia is one of the physiologic changes that occur during flight as a
result of the cabin pressurization. Hypoxia can have effect the circulation by causing
local coronary and cerebral vasodilatation, increase in heart rate, hyperventilation,
increase in blood pressure, increased myocardial contractility, increase in cardiac
pressure, increase in cardiac output and increase in pulmonary artery pressure (Bartsch &
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Gibbs, 2007). In addition to the effect of altitude and cabin pressurization on oxygen
partial pressure in healthy adults, there is an age related decrease in oxygen partial
pressure that occurs above the age of 40 years which is approximated to be a loss of 5
mm Hg per decade of age (Smith et al., 2010).
Patients who present to their primary care provider requesting a medical
certificate of fitness to fly, approval for use of portable oxygen concentrators for air
travel, a pregnancy information form, or a medical information form (MEDIF) for air
travel should trigger preventive screening for the status of current health conditions that
may be affected by the stressors of travel and the aircraft environment. Primary care
providers completing these supporting documents need to have an understanding of the
impact of air travel on medical issues and use available information and prudent
judgment before establishing a patient’s approval to fly in order to prevent patient
adverse health events as well as the potential liability issues that can occur with negative
outcomes. Recommendations from the British Medical Association (BMA) advise health
care providers to carefully word statements on an individual’s fitness to fly indicating the
information on which the healthcare provider’s advice is based rather than providing a
positive certification of a person’s fitness to fly (UK Civil Aviation Authority, 2007).
BMA recommendations include the use of statements on MEDIF forms such as:
I know of no obvious reason why this person should not fly or
There is nothing available in the medical record to indicate that flying may place
this patient at a health risk
These types of statements do not provide a guarantee of a patient being able to travel
without incident but rather indicate that evidence available to the healthcare provider
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does not indicate that air travel will place their patient at a greater risk than other
traveling passengers.
The proposed next step of translation of the capstone project findings will be to
submit the capstone guidelines recommendations, once approved by the capstone
committee and successfully defended, for a review and recommendation of approval by
subject matter experts at the International Society of Travel Medicine. Capstone
recommendations will be summarized for an invited podium presentation at the American
Academy of Nurse Practitioner 2012 National Conference. The summarized clinical
practice guidelines will be submitted to the Journal of the American Academy of Nurse
Practitioners for publication consideration. Publication in a peer-reviewed primary care
journal is preferential so that the information can reach the intended audience of primary
care professionals who may benefit from integrating the capstone project findings into
practice.
The Aerospace Medical Association (2009) estimates that 62% of in-flight
emergencies occur in passengers with pre-existing medical conditions. Preparation and
thorough screening of passengers with known medical conditions would prevent most inflight medical emergencies (Valani et al., 2010). Further examination and research
related to air travel health issues for passengers with comorbid conditions is needed
especially in light of the fact that the air travel population is aging and therefore more
likely to have one or more comorbid conditions that could be adversely affected by air
travel. Traveling passengers may be reluctant to disclose pre-existing medical
information to airline personnel that could prohibit them from a planned flight, especially
when such a delay may cause the passenger to incur additional fees and financial
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consequences associated with disrupted travel plans. Preventive evaluation,
identification and proactive management of conditions by healthcare providers who are
knowledgeable regarding the risks associated with air travel can reduce air travel related
adverse health events. Health care providers who have an understanding of the
physiologic changes that occur in flight can provide individual plans of prevention
tailored to meet the specific conditions of at-risk patients.
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APPENDIX A: AERSOPACE MEDICAL ASSOCIATION RECOMMENDATIONS
FOR ONBOARD EMERGENCY MEDICAL KIT
Medication

Equipment

Epinephrine 1:1000

Stethoscope

Antihistaminic Injectable

Sphygmomanometer (electronic preferred)

Dextrose 50% inj. 50 ml (or
equivalent)
Nitroglycerin tab. or spray

Airways, oropharyngeal (appropriate range of
sizes)
Syringes (appropriate range of sizes)

Major analgesic, inj. Or oral

Needles (appropriate range of sizes)

Sedative anticonvulsant inj.

Intravenous catheters (appropriate range of sizes)

Antiemetic inj.

Antiseptic wipes

Bronchial dilator inhaler

Gloves (disposable)

Atropine inj.

Sharps disposal box

Adrenocortical steroid inj.

Urinary catheter

Diuretic inj.

System for delivering intravenous fluids

Medication for postpartum bleeding

Venous tourniquet

Sodium chloride 0.9% (minimum 250
ml)
Acetyl Salicylic Acid (aspirin) for oral
use
Oral beta blocker

Sponge gauze

A list of medications (Generic names
with trade names if and as it appears
on the item

Emergency tracheal catheter (or large gauge
intravenous cannula

Tape Adhesive
Surgical mask

Umbilical cord clamp
If a cardiac monitor is available (with
or without an AED) add to the above
list:
Epinephrine 1:10000 (can be a dilution
of epinephrine 1:1000)

Thermometer

Basic Life Support and Advanced Life Support
cards
Bag-valve mask
Flashlight and batteries (Operator may decide to
have one per aircraft in an easily accessible
location)
A list of equipments
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APPENDIX B: INCUBATION AND INFECTIVITY COMMUNICABLE DISEASE
INCUBATION PERIODS OF IMPORTANT INFECTIONS
INCUBATION PERIOD
Maximum Range
Usual Range
Anthrax
2-5 days
Amoebiasis
14-28 days
21 days
Bacillary Dysentery
1-7 days
Brucellosis
7-21 days
Chicken Pox
14-21 days
* Infectious 5 days before rash –
6 days after last lesion
Cholera
Hours – days
2-3 hours
Diptheria
2-5 days
* Infectious 2-3 weeks, shorter
with antibiotic therapy
Filariasis
3+ months
Gonorrhea
2-5 days
Hepatitis A
2-6 weeks
4 weeks
Hepatitis B
6wks – 16 mos
12 weeks
Leishmaniasis (cutaneous)
1 wk –months
Leishmaniasis (visceral)
2 weeks – 12 years
2-4 months
Leprosy
Months – years
Malaria
10-14 days
Measles
7-14 days
* Infectious from onset of
prodromal symptoms until 4 days
after onset of rash
Meningococcacemia
2-10 days
3-4 days
Mumps
12-21 days
* Infectious days before salivary
swelling – 7 days after
Pertussis
7-10 days
* Infectious 7days after exposure
to 3 weeks after onset of rash,
shortened to 7 days by antibiotics
Poliomyelitis
3-21 days
7-10 days
Psittacosis
4-14 days
10 days
Rabies
Variable
2-8 weeks
Rubella
14-21 days
* Infectious 7 days before onset
of rash – 4 days after
Scarlet Fever
1-3 days
* Infectious 10-21 days after
onset of rash, shortened to 1 day
by antibiotics
Smallpox
7-17 days
11 days
Trypanosoma (rhodesiense)
14-21 days
Trypanosoma (gamiense)
weeks - years
Typhoid fever
7-21 days
Typhus fever
7-14 days
12 days
INFECTION

‘
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APPENDIX C: ACE STAR MODEL OF KNOWLEDGE TRANSFORMATION

Retrieved from: http://www.acestar.uthscsa.edu/acestar-model.asp
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APPENDIX D: GRADE SYSTEM TABLE

Retrieved from http://www.ichrc.org/evaluate.html
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APPENDIX E: UNLV BIOMEDICAL IRB NOTICE OF EXCLUDED ACTIVITY

Biomedical IRB
Notice of Excluded Activity
DATE:

October 18, 2011

TO:

Dr. Mary Bondmass, Physiological Nursing

FROM:

Office of Research Integrity – Human Subjects

RE:

Notification of review by /Cindy Lee-Tataseo/Cindy Lee-Tataseo, BS, CIP, CIM
Protocol Title: Clinical Practice Guidelines for Primary Care Providers' Evaluation
of Patient Fitness to Fly
Protocol# 1110-3942M
__________________________________________________________________________________
This memorandum is notification that the project referenced above has been reviewed as indicated in
Federal regulatory statutes 45CFR46.
The protocol has been reviewed and deemed excluded from IRB review. It is not in need of further
review or approval by the IRB.
Any changes to the excluded activity may cause this project to require a different level of IRB review.
Should any changes need to be made, please submit a Modification Form.
If you have questions or require any assistance, please contact the Office of Research Integrity –
Human Subjects at IRB@unlv.edu or call 895-2794.
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APPENDIX F: SUMMARY OF EVIDENCE TABLES
Evidence Table: Cardiovascular Disorders
Author/Year

Study Design

Ingle, 2011

Cross-sectional
Survey

Study Purpose/Study
Sample
Study Intervention
Study Outcome
Purpose: Evaluate air travel
experiences of stable chronic
heart failure (CHF) patients
Sample Size: 464/1293 (39%
response rate) cohort of
patients from UK community
heart failure clinic
Intervention:
travel by commercial aircraft
Outcome:
Location of health problems:
to airport, to flight-gate,
through security, during
flight, disembarkation, to
destination, at destination
Type of health problems:
breathlessness, dizziness,
ankle edema, headache, chest
pain, fatigue, labored
walking, palpitations, angina
or defibrillator firing.

IATA, 2011

Executive
summary of the
International Air
Transport
Association of
travel
restrictions
based on expert
opinion

Purpose: Establish a guide to
the timeframe that should
elapse between a medical
event and commercial air
travel
Studies utilized to establish
recommendation were not
identified in the report.

Results

GRADE
Quality of
Evidence

65 % (165/252) no
health-related problems
35% (46/262) problem
at one
location,6%(16/252) at
two locations, 5%
(12/252) at three
locations and 5% at
more than three
locations
9% (8/89) problem with
security at airport due
to pacemaker/ICD
9% (8/89) in-flight
dyspnea, dizziness,
edema, headache and
chest pain
3/8 experiencing
dyspnea required O2
supplementation
25% (22/89) had
health-related
cardiovascular
problems at final
destination
2/22 had defibrillator
firing
27% (125/464) would
not fly in future due to
difficulty (32%), health
concerns (23%)
Patients are cleared to fly
without restriction who have
the following cardiovascular
conditions:
Angina – no restriction if
controlled at rest

●●○○
Low

MI (uncomplicated): after ≥
10 days
Cardiac Failure:
controlled(able to walk 50
meters or climb one flight of
stairs on room air at a normal
pace without breathlessness)
and condition is stable.
In-flight oxygen needs to be
considered
Pulmonary Edema: resolved
and any precipitating
condition
May need to comply with MI
rules
Cardiac Surgery:
after ≥ 10 days
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●○○○
Very low

Angiography:
after ≥ 24 hours if original
condition stable
Angioplasty:
after ≥ 3 days if
asymptomatic
Pulmonary embolism:
≥ 5 days if anticoagulation
stable and PaO2 normal on
room air

Smith, 2010

Review of
clinical studies
and development
of expert
consensus
statement by
British
Cardiovascular
Society

Purpose: establish guidance
for general practitioners and
passengers to determine the
risks of travel by commercial
air for patients with
cardiovascular disorders.
Studies utilized to establish
recommendation were not
identified in the report.

All other conditions require
“assessment by a doctor with
aviation medicine
experience” (IATA, 2011 p.
53).
Travel post acute MI:
Low risk passengers
(age <65 years, fist
event, successful
reperfusion, EF> 45%,
no complications and
no planned
interventions)
post acute coronary
syndrome may safely
fly as early as 3 days
after event.
Medium risk (EF>40%,
no symptoms of heart
failure, no evidence of
inducible ischemia or
arrhythmia and no
further interventions
planned) may fly 10
days after
High risk (EF<40%
with signs and
symptoms of heart
failure, those pending
further investigation
and possible
revascularization or
device therapy) defer
until stable
Chronic Heart failure:
Stable without recent
changes in symptoms or
medication clear to fly.
NYHA class IV
symptoms may require
in-flight O2
Arrhythmia:
symptomatically stable
with low frequency of
events, no restriction
permanent or persistent
atrial fibrillation,
should be be stable with
rate control and
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●○○○
Very low

anticoagulation before
flying
uncontrolled
hemodynamically
significant ventricular
arrhythmia should not
travel on commercial
aircraft
Cyanotic congenital heart
disease: (Eisenmenger
syndrome) – no restriction
but O2 in-flight may be
needed
Cardiac catheterization: delay
flight for one day post
uneventful procedure
Elective PCI:
uncomplicated delay flying
for 2 days
Pacemaker insertion:
in absence of post-insertion
pneumothorax or other
complications, delay flight 12 days after implantation
Ablation:
delay until stable
anticoagulation
Open heart surgery: including
coronary artery bypass
grafting and valve
replacement
- without complications delay
10 days for travel. 10days –
6 wks postop may require
ground assistance

Ross, 2004

Executive
summary of
Canadian
Cardiovascular
Society based on
expert opinion

Purpose: establish
recommendations for fitness
of passengers with
cardiovascular disease to fly
on commercial airlines.
Fitness to fly
recommendations based on
New York Heart Association
(NYHA) functional class

Pacemakers and ICDS:
stable, may travel without
restriction
Angina Pectoris:
I & II - no restriction
III - supplemental O2
IV only if medically
necessary and accompanied
by physician with attached
ECG/defibrillator, O2 and
appropriate medications
Post MI:
I delay travel one to two
weeks if uncomplicated
II to IV – only if medically
necessary and accompanied
by physician with attached
ECG/defibrillator, O2 and
appropriate medications

Heart failure:
I & II – unrestricted
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●●○○
Low

III - supplemental O2
required
Valvular disease:
I & II – unrestricted,
supplemental O2 if
pulmonary hypertension
III - supplemental O2
required
IV – only if medically
necessary and accompanied
by physician with attached
ECG/defibrillator, O2 and
appropriate medications
Congenital disease:
I & II – unrestricted,
supplemental O2 if PaO2 <
70mmHg
III - supplemental O2
required
IV – only if medically
necessary and accompanied
by physician with attached
ECG/defibrillator, O2 and
appropriate medications
Post-CABG/valve surgery:
I-II- 4 days postop if
hemoglobin ≥ 90g/L if flight
< 2 hours or 7 days postop if
hemoglobin ≥ 90g/L if flight
≥ 2 hours
Therapeutic interventionPCI/ASD closure:
I-II – 1 day postprocedure. If
PCI following MI, follow
post-MI guidelines
Arrhythmia/post arrhythmia
procedure:
I-II – unrestricted if wellcontrolled supraventricular
arrhythmia, 2 days post
procedure for ventricular
arrhythmias
II-IV – restrict flying by
commercial aircraft if
uncontrolled
hemodynamically significant
ventricular arrhythmia
Post-pacemaker/ICD/loop
recorder implant:
I-II – delay flight 1 day
postimplant if no
pneumothorax and device
functions normally and is
programmed appropriately

Roby, 2002

Randomized,
single-blind,
controlled trial

Purpose:
1)

Examine the safety of
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ICD patients:
I-II – delay travel 1 month
following last intervention
from device associated with
severe presyncope /syncope
2% (1/38) Myocardial
ischemia diagnosed by Holter
monitor

●●●○
Moderate

2)

3)

patients traveling by
commercial air 2 weeks
after myocardial
infarction (MI)
Determine if
supplemental oxygen
was associated with
reduced risk of in-flight
adverse events
Determine the need for
a medical escort

Sample : 38 patient with
mean of 15-16 days post
acute Myocardial Infarction
Intervention:
travel by commercial aircraft
Oxygen
Outcomes:
Major endpoint:

13% (5/38) decreased O2
saturation
2 % (1/38) evidence of S-T
depression
5% (2/38) chest pain
13% (5/38) ventricular
ectopy or tachycardia
No difference in minor
endpoints between O2 (5/13)
and non-O2 (6/15) groups
(p=0.93)

Myocardial ischemia
detected by Holter
monitoring
Minor endpoints:

ASMA, 2003

Recommendatio
ns based on
expert opinion
for primary care
and specialist
physicians to
advise patients
with medical
conditions

Chest pain
Dyspnea
O2 saturation <90%
Purpose: establish
recommendations for fitness
of passengers with
cardiovascular and other
medical diseases to fly on
commercial airlines
Studies utilized to establish
recommendation were not
identified in the report.

Uncomplicated acute MI:
Delay travel 2-3 weeks after
resumption of usual daily
activities
Old MI: no contraindication
unless significant angina or
left ventricular dysfunction
Severe decompensated CHF:
flying contraindicated
CABG and other chest
surgeries: no risk after fully
recovered without
complications. Recommend
10-14 day delay post surgery
to prevent risk associated
with barotraumas
PCI: uncomplicated: no risk
after fully recovered without
complications.
PCI: complicated: delay
travel 1-2 weeks
Symptomatic valvular heart
disease – flying
contraindicated
Hypertension: no
contraindication if controlled
Pacemakers/ICD: no
contraindication if controlled
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●○○○
Very Low

Zahger, 2000

Longitudinal
Study

Purpose: evaluate patients
returning by commercial air
after acute coronary
syndrome, effect of timing
and short-term complications
Sample: 21 tourists admitted
to an Israeli coronary care
unit with acute coronary
syndrome between May 1996
– May 1999.
Intervention:
travel by commercial aircraft
Outcomes:
- flight duration
- symptoms during flight
- recurrent angina requiring
hospitalization
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Cardiovascular
contraindications to
commercial airline flight:
1. Uncomplicated MI within
2-3 weeks
2. Complicated MI within 6
weeks
3. Unstable angina
4. Congestive heart failure,
severe, decompensated
5. Uncontrolled hypertension
6. CABG within 10-14 days
7. CVA within 2 weeks
8. Uncontrolled ventricular or
supraventricular tachycardia
9. Eisenmenger syndrome
10. Severe symptomatic
valvular heart disease
Days from acute event to
flight home 18.2 ± 11 days
Flight duration 12.5 ± 3 hours
0 - Cardiac symptoms in
flight
90% - 19/21 remained
symptom free at follow up 21
days ± 13

●○○○
Very Low

Evidence Table: Respiratory Disorders
Author/Year

Study Design
Level of Evidence

Akero, 2011

Randomized crossover
trial

Study Purpose/Study Sample
Study Intervention
Study Outcome

Results

Purpose: evaluate efficacy of preflight testing of COPD patient’s to
predict oxygen needs at 8,000 ft
altitude

Without supplemental
O2, PaO2 was lower
during the HAST than
in the HC (p=0.005)

Sample: 16 patients with COPD
from two Norwegian outpatient
pulmonary clinics

56% (9/16) patients
reported dyspnea
during exposure to
hypoxia.

Interventions:
Hypoxia induced by a hypoxiaaltitude simulation test (HAST)
and in a hypobaric chamber (HC)
Oxygen
Outcome:
Pao2 with and without
supplemental oxygen
Secondary outcome – comparison
of effect of Pao2 on various types
of oxygen equipment in the HC

Tam, 2011

Cross-sectional survey

Purpose: evaluate the safety of air
travel after percutaneous
transthoracic needle biopsy
(PTNB)
Study population: 179 patients
who underwent PTNB followed
by air travel within 14 days of the
procedure. 36% (65/179) patients
experienced a post-biopsy
pneumothorax prior to travel.
Intervention:
travel by commercial aircraft
Outcomes:
In-flight medial event requiring
attention or diversion
Worsening of existing respiratory
symptoms or new onset of
respiratory symptoms
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GRADE
Quality
of
Evidence
●●●○
Moderate

Continuous oxygen at
2L/min or an oxygen
conserving device at
pulse setting 2 is
needed to reach an
Spo2 of 90% (p<.001)
In-flight physical
activity resulted in a
drop in Spo2 and
increased supplemental
oxygen.
In a HC simulating
altitude of 8,000ft,
compressed gaseous O2
with continuous flow
or with an oxygenconserving device
resulted in the same
Pao2. Portable Oxygen
Concentrator (POC)
showed significantly
lower Pao2 values than
continuous flow or
oxygen conserving
devices (p=.003)
81% of all patients and
77% of patients with
post-biopsy
pneumothorax traveled
within 4 days of the
final post-biopsy chest
radiograph.
No patient reported inflight medical events
8% (14/179)
experienced worsening
of existing respiratory
symptoms or new onset
of symptoms during or
after the flight.

●●○○
Low

Bossley, 2011

Case Control Study

Perform fitness to fly tests using a
body plethysmograph in expreterm babies without
bronchopulmonary dysplasia
(BPD) and compare them with
normal term babies to determine
whether routine prefight testing
should be recommended in expreterm babies without BPD.
41 term infants and 30 ex-preterm
infants recruited from neonatal
units and postnatal wards in
Australia

Intervention:
Hypoxia induced environment in
sealed body plethysmograph
Outcomes:
Changes in SpO2, pulse and FiO2
Edvardsen, 2011

Case Control Study

Purpose: determine the prevalence
of in-flight symptoms in COPD
patients and non-COPD subjects
and to evaluate associations
between symptoms and pre-flight
variables
Subjects: 391 COPD patients and
184 non-COPD subjects were
recruited from hospital and
specialist practices in Norway. Of
the recruited patients, 54%
(211/391) with COPD and 86.4%
(159/184) flew during the
previous 2 years
Intervention:
travel by commercial aircraft
Outcomes:
lung function, blood gas values,
Medical Research Council (MRC)
dyspnea scale , 6-minute walk
test, air travel habits (frequency &
duration of travel, pre-flight
medical consultation) and inflight symptoms (dyspnea,
dizziness, headache, chest pain,
air hunger, cough, fainting,
palpitations)

IATA, 2011

Executive summary of
the International Air
Transport Association
of travel restrictions
based on expert
opinion

Purpose: establish a guide to the
timeframe that should elapse
between a medical event and
commercial air travel
Studies utilized to establish
recommendation were not
identified in the report.
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All subjects
experienced a
significant desaturation
(median drop of 6%)
when breathing FiO2
0.15.
No difference was
noted between the
healthy term and expreterm babies at 3 or 6
months corrected
gestational age during
testing.
Feeding at FiOs 0.15
resulted in a significant
drop in SpO2 for both
groups (P<0.0001)
without any significant
difference among
groups. The fall in
SpO2 occurred at the
initiation of feeding
and was transient.
One or more hypoxia
related symptoms were
reported by 24.6%
(52/211) of the COPD
group and by 8.8%
(14/159) of the nonCOPD group (OR =
3.4, 95% CI, 1.8-5.4, p
< 0.001).

●●○○
Low

●●●○
Moderate

COPD patients
experienced
significantly more
frequent hypoxiarelated symptoms of
dyspnea and air hunger
during air travel than
non-COPD subjects
(P<0.001).
Odds ratio for COPD
patients to experience
dyspnea or air hunger
was 6.6 (95% CI, 2.517.3, p<0.001) after
adjusting for smoking
status, age and gender
compared to nonCOPD subjects.
In-flight dyspnea
correlated with preflight sea-level MRC
dyspnea scores.
Patients are cleared to
fly without restriction
who have the following
respiratory conditions:
Pneumothorax – 7 days
after full inflation
Chest surgery ≥ 11
days with
uncomplicated
recovery

●○○○
Very low

Pneumonia – fully
resolved or symptom
free with X-ray signs
persistent
COPD – exercise
tolerance >50 meters
without dyspnea and
stable condition. Full
recovery if recent
exacerbation.

Thamm, 2011

Cross-sectional survey

Purpose: determine the proportion
of patients with pulmonary
hypertension (PH) who had
travelled by air contrary to
medical advice
Subjects: 430 patients completed
the survey sent to 720 patients
(60% response rate). 42%
(179/430) had flown since PH
diagnoses.
Intervention:
travel by commercial aircraft

Ahmedzai, 2011

Review of clinical
studies and
development of expert
consensus statement
by British Thoracic
Society

Outcomes:
Worsening of respiratory and new
onset of other health symptoms
Purpose: establish guidance for
general practitioners and
passengers to determine the risks
of travel by commercial air for
patients with respiratory disorders.

Studies utilized to establish
recommendation were not
identified in the report.

All conditions not
meeting above
requirements for
clearance should have
“assessment by a
doctor with aviation
medicine experience”
(IATA, 2011 p. 54).
89% (159/179) had no
adverse events during
or directly after their
air travel
11% (20/179) reported
one or more events
associated with travel –
3.4 %( 6) dyspnea
3.4% (6), peripheral
edema, 3 (1.7%)
exhaustion, 2 (1.1%)
heart palpitations, chest
pain, headache or
worsening of general
condition.

Summary of potential
risks posed by air
travel by condition:
Asthma & COPD:
acute bronchospasm,
hypoxemia or infective
exacerbation
Bronchiectasis:
hypoxemia, infective
exacerbation
Lung cancer:
hypoxemia, overall
deterioration or sepsis
Cardiac comorbidity:
myocardial ischemia,
hypoxemia,
arrhythmia, peripheral
edema, venous
thromboembolism,
worsening of heart
failure
Hyperventilation or
dysfunctional
breathing: acute
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●●○○
Low

●○○○
Very low

exacerbation
Airborne infections:
hypoxia, transmission
to other passengers
HIV infection:
exacerbation of preexisting opportunistic
infection
Interstitial lung
disease: hypoxemia,
infective exacerbation
Neuromuscular disease
and kyphoscoliosis:
hypoxemia
Obstructive sleep
apnea syndrome
(OSAS): worsening
hypoxemia when
asleep, exacerbation of
jet lag with potential
adverse effect on
driving
Obesity: hypoxemia,
VTE
Pneumothorax: 38%
expansion of residual
air at 8000ft; possible
recurrence within at
least 1 year unless
pleurodesis has been
performed via
thoracotomy
Pulmonary
arteriovenous
malformations
(PAVM): hypoxemia,
stroke, VTE and
PAVM hemorrhage
Sinus and middle ear
disease: barotraumas
Thoracic surgery: 38%
expansion of residual
air at 8000 ft

Tiemensma, 2010

Case study report

Patient being treated for
pulmonary tuberculosis with a
medical history which included
drainage of pneumothoraces and
pleural effusions

At risk of VTE:
increased risk of VTE
on all flights especially
those >8 hour or
following multiple
shorter journeys over a
short period.
Patient experienced
shortness of breath and
chest pain shortly after
take-off and
subsequently died from
pneumothorax.
Patients with
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●○○○
Very
Low

Lapostolle, 2009

Kelly, 2009

Case study report

Longitudinal cohort

Two, 26 year old, female patients
traveling long-distance (17,000km
and 20:45h) suffered sudden
asystolic cardiac arrest upon
arrival

Purpose: quantify the hypoxemic
response to air travel and to
identify baseline correlates to
predict the response in passengers
with non-obstructive lung disease.
Subjects: 14 volunteers (7
female/7 male)
Intervention:
Hypoxemic challenge test
Travel by commercial aircraft
Outcomes:
respiratory function testing,
in-flight SpO2, cabin pressure and
dyspnea and post flight hematocrit
level

Lehmann, 2009

Cross-sectional survey

Purpose: evaluate the incidence of
travel-associated pulmonary
embolism (PE)
Subjects: 257 patients with PE as
primary diagnosis at discharge
Outcome:
Prognosis post event

pulmonary diseases
need pre-flight
evaluation and possible
supplemental oxygen
in –flight to prevent
complications.
Embolectomy and clot
examination revealed
that both pulmonary
emboli were newly
formed.
The most likely risk
factor for pulmonary
embolism was long
distance air travel
13/14 subjects
experienced in-flight
significant hypoxia
(SpO2 <89%)

●○○○
Very
Low

Respiratory function
did not predict in-flight
desaturation.
Pre-flight SpO2
measures had strongest
correlation (r=0.91,
p<0.001) with in-flight
SpO2.
Respiratory function
testing showed no
correlation with inflight measurements or
the Hct response.
In-flight desaturation
did not correlate with
increased symptoms of
respiratory distress.
18% (45/257) patients
were identified to have
PE associated with air
travel, only patients
with idiopathic PE
(32%, n= 83) and
thrombophilia (30%,
n=78) occurred with
more frequency.
Intrahospital mortality
was not statistically
significant between
both groups (4.3%
overall)
3-month mortality rate
in both groups was
similar (p>0.999).
Low incidence of
flight-associated PD
(0.2 cases per 1 million
passengers arriving at
Frankfort airport)
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●○○○
Very
Low

●●○○
Low

Taveira-DaSilva,
2009

Cross-sectional study

Purpose: determine the prevalence
of pneumothorax associated with
air travel in patients with
lymphangioleiomyomatosis
(LAM), idiopathic pulmonary
fibrosis (IPF) and sarcoidosis
Subjects: 281 subjects with LAM,
76 with IPF and 92 with
sarcoidosis admitted to NIH
Clinical Research Center.
Intervention:
travel by commercial air
Outcome:
new onset pneumothorax

Martin, 2008

Case-control study

Purpose: investigate how well the
pre-flight hypoxia test cutoff
values of 85% and 90%
discriminated between health
children and those with neonatal
chronic lung disease (nCLD).
Subjects: 34 healthy children and
35 children with a history of
nCLD.
Intervention:
Hypoxia challenge test
Outcomes:
SpO2 and heart rate

Kelly, 2008

Longitudinal cohort

Purpose: assess the predictive
capability of the hypoxia
inhalation test (HIT) in passengers
with COPD
Subjects: 13 volunteers with
COPD (7 female)
Intervention:
Hypoxia inhalation test
Travel by commercial aircraft
6-minute walk test
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compared with other
trial estimates
2% (7/281) LAM
patients had evidence
of a new
pneumothorax.

●●○○
Low

Pneumothorax patients
did not experience
symptoms of dyspnea
or chest pain during
travel
Prior history of
pneumothorax
correlated 100% to
new onset
pneumothorax
diagnosis in LAM
patients.
None of the patients
with IPF or sarcoidosis
presented with
pneumothorax.
90% cutoff value did
not discriminate
between the two
groups. 12/24 healthy
and 14/23 nCLD failed
the hypoxia test
(p=0.56)

●●○○
Low

85% was more
discriminatory test.
1/24 healthy and 6/23
nCLD failed hypoxia
test (p=0.048)
In both groups children
> 2 years passed the
hypoxia test at 90%.
Children with nCLD
who were <2 years had
an increased risk of
failing the hypoxia test
at 85% cutoff (p =
0.039) and a
correlation was noted
with failure and
neonatal supplemental
oxygen use
Air travel caused
significant desaturation
preflight (95 ± 1%);
mean in-flight (86 ±
4%) which was
worsened by activity
(78 ± 6%).
HIT resulted in
desaturation
comparable to that of
air travel (84 ± 4%).

●●○○
Low

Outcomes: respiratory function,
pulse oximetry, cabin pressure
and dyspnea

Mean in-flight partial
pressure of inspired
oxygen (PIO2) was
higher than the HIT
PIO2 (113 ± 3 mm HG
vs. 107 ± 1 mm Hg, p
<0.001)
The strongest
correlation was found
between the HIT SpO2
and in-flight SpO2(r =
0.84; p<0.001)

Jones, 2008

Quasi-experimental

Purpose: evaluate the role of
ventilation-perfusion ratio (VA/Q)
and pulmonary shunt on SpO2 of
patients with pulmonary
dysfunction when exposed to
air/nitrogen mixtures as cabin
pressure (PIO2) falls.
Subjects: 18 patients with chronic
lung disease
Intervention: airline equivalent
hypoxia delivered by nitrogen
mixtures of 17kPa (equivalent to
5000 ft altitude) and 15kPa
(equivalent to 8000 ft altitude)
Outcomes:
PIO2 vs. SpO2 along the PO2 axis
and. VA/Q shunt (change of shape
and downward shift of the same
curve)

Broberg, 2007

Cross-sectional survey

Purpose: analyze experience and
determine incidence of adverse
events in patients with
Eisenmenger syndrome who
travel by air compared to controls
with known congenital heart
disease (CHD)
Subjects: 53 adult patients with
Eisenmenger syndrome, 48
acyanotic patients with known
CHD
Intervention:
travel by commercial aircraft
Outcomes:
Major adverse events requiring
hospitalization: stroke, ischemic
chest pain, syncope or heart
failure
Minor adverse events: headache,
edema, supplemental oxygen
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During hypoxia, the
lowest SpO2 was
correlated with reduced
VA/Q (R2=0.89).

●●○○
Low

9/10 patients with
VA/Q ≤ 0.69 developed
profound hypoxia. 5/9
hypoxic had ground
level SpO2 ≥ 92%.
Patients with VA/Q
>0.70 maintained SpO2
≥84%.
Reduced VA/Q
predisposed to a
greater degree of
hypoxemia than
increased shunt at
15kPa PIO2.
Measurement of VA/Q
and shunt during
hypoxic hypoxia
improves prediction of
patient need for
supplemental O2 during
air travel
No difference was
found between groups
for use of supplemental
oxygen during flight (1
of each group)
Nonsignificant
incidence in report of
headache during flight
(6/40, 9%)
Eisenmenger and
(4/48, 9%)control
subjects)

●●○○
Low

Currie, 2007

Case Report

required during flight
Evaluation of two adult patients
with history of chronic
pneumothorax requesting fitness
to fly exams
Subject : 36 year old male smoker
and 31 year old female smoker
both with history of stable
pneumothorax for > 1 year
Evaluation: review of history,
clinical assessment, computed
tomographic imaging, hypoxic
challenge test and exposure to
hypoxic hypobaric environment in
a decompression chamber

Udomittipong,
2006

Cross-sectional
retrospective review

Purpose: identify clinical factors
predictive of an in-flight oxygen
requirement from a review of
hypoxia challenge tests in infants
referred for fitness to fly
assessment
Subjects: 47 infants with a history
of neonatal lung disease not
receiving O2 at the time of
hypoxia testing
Intervention:
Hypoxic challenge test
Outcome:
SpO2, pulse rate and activity state

Kelly, 2006

Quasi-experimental

Purpose: quantify the degree of
desaturation in healthy subjects
during a normobaric hypoxia
inhalation test (NHIT) and air
travel and to assess the validity of
the NHIT when compared with
actual in-flight responses
Subjects: 15 health adults (age 2357 years: 10 women) volunteers
Intervention: NHIT (inspired
oxygen 15%), cruising altitude in
commercial aircraft
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Both patients sustained
oxygen saturations
>90% during testing
and were
asymptomatic.

●○○○
Very
Low

Both patients
successfully traveled
by air without adverse
events.
Patients with closed
chronic pneumothorax
can fly without adverse
consequences. Risk
determination should
be made through
assessment, CT of
chest, a hypoxic
challenge test and
simulation of flying at
altitude in a
decompression
chamber with close
monitoring of
symptoms and oxygen
saturation.
81% of children
studied exhibited
desaturation below
85% during hypoxic
testing despite all
infants having normal
room air SpO2 ≥ 95%.

●●○○
Low

Age at the time of
hypoxia test
significantly predicted
the outcome of the
hypoxia test (OR 0.82;
95% CI 0.62-0.95; p =
0.005).
Children passing the
hypoxia test were
significantly older (12
months vs. 37 weeks)
than those requiring inflight oxygen
(p<0.0001).
Significant
desaturation was noted
during NHIT (pre: 98 ±
2%; post 92 ± 2%) and
at cruising altitude
(pre: 97 ± 1%; post 92
± 2%)
No difference was
found between the final
NHIT SpO2 and the
mean in-flight SpO2.
Significant difference

●●○○
Low

Almeida, 2006

Humphreys, 2005

Case study

Prospective cohort
study

Outcomes: lung function, arterial
blood gas, pulse oximetry. Inflight oxygenation was compared
with preflight NHIT.
71 year-old male experiencing
right-sided chest discomfort
shortly after take-off of a
commercial flight, followed by
headache and sudden loss of
consciousness
48-72 hours patient admitted to
prior treating facility was noted
that CT scan performed prior
imaging studies revealed a right
pulmonary cyst
Purpose: determine the degree of
hypoxemia during short haul and
long haul air travel
Subjects: 84 passengers (55 long
haul > 2 hr duration and 29 short
haul < 2 hr duration) aged 1-78
years. Subjects were anesthetists
and their traveling companions;
each passenger was their own
control).
Intervention:
travel by commercial air

Closon, 2004

ASMA, 2003

Case Report

Recommendations
based on expert
opinion for primary
care and specialist
physicians to advise
patients with medical
conditions

Outcomes:
SpO2
43 year-old male asthmatic
smoker experiencing sudden loss
of consciousness followed by
dyspnea and agitation 20 minutes
after take-off of a commercial
flight.
Flight diverted and patient was
admitted to ICU, CT scan
demonstrated right lower lube
bulla.
Establish recommendations for
fitness of passengers with
pulmonary and other medical
diseases to fly on commercial
airlines
Studies utilized to establish
recommendation were not
identified in the report.

was noted between the
lowest in-flight SpO2
(88 ± 2%) versus the
lowest NHIT SpO2 (90
± 2%)
Authors posit that preexisting
intrapulmonary cyst
expansion led to
leakage of air into the
surrounding vessels
followed by brain gas
emboli.

●○○○
Very
Low

Statistically significant
reduction in SpO2 in all
passengers traveling
regardless of flight
duration (p<0.05).

●●○○
Low

Mean ground level
SpO2 was 97% (93100; 1.33) and at
cruising altitude was
93% (85-98; 2.33)
54% of healthy
passengers had SpO2 ≤
94% at cruising
altitudes
Diagnosis of air
embolism involving
the brain and heart was
made based on the
presence of the
pulmonary cyst.

●○○○
Very
Low

Ground level PaO2 of
>70 mm Hg does not
require restriction.

●○○○
Very
Low

PaO2 of <70 mm Hg
may be effectively
managed with in-flight
medical oxygen
therapy.
Hypercapnea (elevated
Pco2 = poor pulmonary
reserve and indicates
potential risk at
altitude, even with
oxygen therapy.
Fitness to fly testing:
Most practical: 50 yard
walk without severe
dyspnea
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More sophisticated
testing: hypoxia
altitude simulation test
or HAST. If Pao2 is
low during testing (<55
mm HG), medical
oxygen must be
considered.
Asthma – air travel
contraindicated if
asthma is labile, severe
or passenger has had
recent hospitalization.
COPD – preflight
evaluation by Pao2,
HAST or ability to
walk & climb stairs is
extremely important

Bronchiectasis and
cystic fibrosis – no
restriction if lung
infection controlled
and secretions are
loose and clear
Pneumothorax – travel
contraindicated for 2-3
weeks after successful
draining.
Pleural effusion –
delay travel for 14 days
post drainage and
clearance by CXR
prior to travel
Pulmonary vascular
disease – medical
oxygen,
anticoagulation and
restriction from
exercise during flight
to reduce risk of
hypoxia-induced
pulmonary
vasoconstriction.
Lee, 2002

Prospective cohort
study

Purpose: determine the degree of
oxygen saturation decline
occurring in children during longhaul commercial air travel
Subjects: 80 healthy children (43
boys) ages 6 mos – 14 years
flying between Honolulu Hawaii
and Taipei, Taiwan.
Intervention: travel by
commercial aircraft
Outcomes: SpO2 and heart rate
preflight at sea level compared to
3 hours and 7 hours in flight.
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Mean SpO2 declined
from mean sea-level
SpO2 of 98.5 to 95.7%
after 3 hours and
94.4% after 7 hours
(p<0.001).
Mean heart rate (BPM)
increased from sea
level of 100 BPM to
105BPM after 3 hours
and 108BPM after 7
hours of flight
(p<0.001 and p=0.01)

●●○○
Low

Evidence Table: Venous Thromboembolism(VTE)
Author/Year

MacCallum,
2011

Study Design
Level of Evidence
Case-control study

Study Purpose/Study Sample
Study Intervention
Study Outcome

Results

GRADE
Quality of
Evidence

Purpose: quantify the risks of VTE
associated with both long-haul air
travel and cumulative flying time.

Patients flying >12 hours within
4 weeks before VTE had a
threefold increase in the risk of
VTE (OR 2.75, 95% CI, 1.445.28)

●●●○
Moderate

Subjects: 550 VTE cases identified
from practice records. 1971 controls.
Intervention: travel by commercial
air
Outcomes:
VTE, duration of travel

Schreijer, 2010

Quasi-experimental

Purpose: determine if hypoxia,
stress, inflammation or viral
infection are contributors to the
prothrombotic state in air travelers.
Subjects: 71 healthy adult volunteers
Interventions:
8 hour flight
8 hour movie marathon
8 hours of regular activities
Outcomes:
Plasminogen activator inhibitor-1
(PAI-1), stress, plasma factor (F)
VIII coagulant activity (FVIIIc),
soluble P-selectine (sP-selectine),
interleukin-8 (IL-8) and neutrophil
elastase.

Patients flying >4 hours within
4 weeks before VTE had a twofold increase risk of VTE (OR
2.2, 95% CI, 1.29-3.73)
No association between flying
time and VTE was noted more
than 12 weeks prior to VTE
diagnosis.
PAI-1 increased by 4.2ng mL-1
(CI95:-49.5 to 6.5) in volunteers
with an activated clotting
system and decreased in those
without (-20.0ng mL-1, CI95:33.2 to-14.0). FVIIIc levels
rose more in individuals with
clotting activation (18.0%, CI
95:-1.0to 33.0) than in those
without (2.0%, CI95: -2.0 to
5.0). The increases in FVIIIc
were not associated with stress,
which was found to be unrelated
to clotting activation. sPselectin increased in those with
clotting activation (3.5 µgL-1,
CI95:-3.0to 10.0) and decreased
in those without
(-0.5 µgL-1, CI95:-2.0to 2.0)
No difference was found in
change in level of neutrophil
elastase or IL-8 between subject
groups.

●●○○
Low

Results of the study do not
support the hypotheses that
stress, infection, or air pollution
are involved in prothrombotic
state development in air
travelers.

Chandra, 2009

Meta-analysis

Purpose: estimate the risk for VTE
in travelers, determine whether a
dose-response relationship exists
and identify reasons for
contradictory results in previous
studies

92

The authors posited that after
long haul air travel, patients
with risk factors may have a
more pronounced state which
may be caused by hypoxia,
triggering systemic
inflammation and platelet
activation resulting in
coagulation induction and
degranulation of platelets.
Compared with non-travelers,
the overall pooled relative risk
for VTE in travelers was 2.0
(95%CI, 1.5-2.7).
Excluding studies that used
referred control participants

●●●○
Moderate

Data Synthesis: 1560 abstracts were
identified of which 14 studies (11
case-control, 2 cohort and 1 casecrossover) met inclusion criteria
including 4055 cases of VTE

Kuipers, 2007

Systematic review
of the literature

Purpose: quantify the risk of VTE
after long-distance travel.
Data Synthesis: 528 Abstracts were
reviewed and screened to 10 casecontrol studies, 20 observational
follow-up studies, 11 intervention
studies and 14 pathophysiological
studies.

Schreijer, 2008

Case-control study

Purpose: Evaluate the effect of
flight-related behavior on the risk of
VTE after air travel
Subjects: 80 patients and 108 control
subjects who had travelled more
than 4 hours by plane within 8
weeks of the data collection.
Intervention: travel by commercial
air
Outcomes:
Venous thrombosis, anxiety, sleep,
seat assignment, exercise, alcoholic
beverage consumption

93

resulted in an increased pooled
relative risk for VTE in
travelers to 2.8 (95% CI, 2.23.7).
A dose-response relationship
was identified with an 18%
higher risk for VTE for each 2hour increase in duration of
travel by any mode (p = 0.010)
and a 26% higher risk for every
2 hours of air travel (p = 0.005).
Long distance travel increased
the risk of VTE two to fourfold.
The absolute risk of VTE within
4 weeks of flights longer than 4
hours is 1/4600 fights. The risk
of severe pulmonary embolism
(PE) occurring immediately
after air travel increases with
duration of travel from 0 in
flights shorter than 3 hours up to
4.8 per million in flights lasting
longer than 12 hours. The risk
of fatal PE immediately after
arrival is estimated at <0.6 per
million passengers in flights
longer than 3 hours. The risk of
VTE is not increased after travel
shorter than 3-4 hours. The risk
of asymptomatic VTE after
long-haul flights ranged up to
12%.
The risk of VTE was slightly
lower in passengers who flew
business class compared to
economy class (OR0.7; 95%CI;
0.2-1.8) Passengers seated in a
window seat had a more than
twofold increased risk of VTE
than passengers who were
seated at an aisle seat (OR 2.2;
95%CI;1.1-4.4). Risk increased
with obesity (BMI>39 kg/m2,
OR 6.1;95%CI:0.5-76.2 after
adjustment for age and gender)
and was also increased in
overweight participants (BMI
25-30 kg/m2, OR 2.6;
95%CI:0.7-9.3).
No increased risk was noted in
passengers who were seated in
the middle seat. The use of
alcohol did not increase the risk
of VTE. Drinking one glass of
alcohol appeared to have a
protective affect compared to
non-alcohol drinkers (OR 0.5;
95%CI: 0.2-1.2).
With every hour of sleep, the
risk of VTE after air travel
increased by 10% (OR 1.10;
95%CI: 0.2-1.2). Passengers
who slept during the flight had a
1.5-fold increased risk of VTE
compared to passengers who did
not sleep during flight.
Subjects who noted anxiety
during travel had an increased
relative risk of thrombosis of

●●●○
Moderate

●●○○
Low

2.5 (OR 2.5; 95%CI: 0.9-7.0).

Kuipers, 2007

Cohort Study

Purpose: to assess the absolute risk
of venous thrombosis after air travel
Subjects: 8,755 employees exposed
to long-haul flight
Outcome: VTE

WHO, 2007

Meta-analysis

Purpose: confirm the risk of VTE is
increased by air travel and determine
the magnitude of risk, the effect of
other factors on the risk and to study
the effect of preventive measures on
risk

Philbrick, 2006

Systematic Review

Purpose: To review the
methodologic strength of the
literature, estimate the risk of travelrelated VTE, evaluate the efficacy of
preventive treatments and develop
evidence-based recommendations
for practice.
Study selection: all clinical studies
reporting primary data concerning
travel as a risk factor for VTE or
testing preventive measures for
travel-related VTE were included
Data Synthesis: 25 studies met
inclusion criteria – 6 case control
studies, 10 cohort studies and 9
randomized controlled trials.

Aryal, 2006

Literature Review

Purpose: to quantify the risk of VTE
following air travel and assess
methods of prevention
Study Selection: 43 studies were
found relevant to the study variables,
18 of which met the inclusion
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Preventive measures of drinking
non-alcoholic beverages,
exercising during flight or
wearing compression stockings
did not have a protective effect.
Incidence rate of 3.2/1000 PY
compared to 1.0/000 PY in
individuals not traveling by air
(IRR 3.2, 95%CI: 1.8-5.6). The
rate was equivalent to a risk of
one VTE per 4,656 long-haul
flights. Risk increased with
exposure to more flights within
a short time frame and with
increasing flight duration.
Higher risks were noted in
travelers less than 30 years,
women using oral
contraceptives and individuals
who were overweight, short or
tall.
Two-fold increased risk of VTE
after long-haul flight of > 4
hours. Increased risk applied to
other forms of travel (car, bus or
train) where travelers were
exposed to prolonged seated
immobility. Risk increases with
the duration of travel and with
multiple flights over a short
period. Obesity, height
extremes, use of oral
contraceptives and the presence
of prothrombotic blood
abnormalities were found to
contribute to increased risk of
travel-related VTE.
The absolute risk of VTE per
more than 4 hours flight in a
cohort of healthy passengers
was 1 in 6,000.
Method of screening for VTE
(ultrasound versus clinical
assessment, OR 390), outcome
measure (all VTE compared to
PE only, OR 21), duration of
travel (<6 hours compared to 68 hours , OR 0.011) and clinical
risk (higher compared to lower
OR 3.5) were significantly
related to VTE rate.
Graduated compression
stockings prevented travelrelated VTE (p<0.05 in 4 of 6
studies). Aspirin and lowmolecular-weight heparin
failed to demonstrate significant
protective benefits in any of the
studies.
An association of VTE with air
travel was found to have a
pooled odds ration 1.59 (CI
1.04-2.43) from three case
control studies and a relative
risk of 2.93 (CI 1.5-5.58) in two
cohort studies.

●●○○
Low

●●●○
Moderate

●●●○
Moderate

●●○○
Low

criteria – 5 case control studies, 2
controlled cohort and 8 randomized
controlled trials.
Outcome:
VTE with air travel

Schwarz, 2003

Prospective,
controlled cohort
study

Purpose: To assess the incidence of
venous thrombosis with long-haul
flights
Subjects: 964 passengers with flight
durations ≥ hours and 1213 nontraveling control subjects.
Intervention: travel by commercial
air

Jacobson, 2003

Prospective study

Outcome:
Venous thrombosis diagnosed by
ultrasound
Symptomatic pulmonary embolism
and death
Purpose: To determine the incidence
of DVT in low and intermediate-risk
passengers comparing passengers
travelling in business and economy
class.
Subjects: 434 subjects
Outcomes:
DVT as
diagnosed by ultrasound, D-dimer
levels
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The incidence of pulmonary
embolism increases when the
distance travelled is more than
5,000 miles (1.5 PE per million
passengers) or the flight time is
more than 8 hours in duration
(2.57 PE/1 million passengers).
The quantitative risk of lower
limb VTE after long haul flights
in high risk-subjects was 5% per
flight and 1.6% per flight in low
risk subjects.
The risk of venous thrombosis
after air travel of ≥ 8 hours
duration was double for isolated
calf muscle venous thrombosis
when compared to non-traveling
controls (RR 2.83, 95% CI,
1.46-5.49)

●●○○
Low

Symptomatic pulmonary
embolism occurred in only 1
passenger (p=.44)

No passengers developed VTE
by ultrasound.
10% of passengers travelling
by air had elevated D-dimer
levels upon arrival at destination
regardless of class travelled by
air (OR 0.61, p=0.038).

●●○○
Low

Evidence Table: Blood Disorders
Author/Year

Study Design
Level of Evidence

IATA, 2011

Executive summary of
the International Air
Transport Association
of travel restrictions
based on expert
opinion

Study Purpose/Study
Sample
Study Intervention
Study Outcome
Establish a guide to the
timeframe that should
elapse between a
medical event and
commercial air travel
Studies utilized to
establish
recommendation were
not identified in the
report.

Results

GRADE
Quality of
Evidence

Patients with hemoglobin
levels <9.5 g/dl should defer
travel until hemodynamically
stable. If acutely anemic, Hgb
level should be assessed more
than 24 hrs after last

●○○○
Very Low

Sickle Cell Disease- travel is
not recommended within 9
days of sickling crises.
Travel clearance can be
provided after 10 days.
Oxygen supplementation is
always needed.
All conditions not meeting
above requirements for
clearance should have
“assessment by a doctor with
aviation medicine
experience” (IATA, 2011 p.
54-55).

ASMA, 2003

Recommendations
based on expert
opinion for primary
care and specialist
physicians to advise
patients with medical
conditions

Establish
recommendations for
fitness of passengers
with pulmonary and
other medical diseases
to fly on commercial
airlines
Studies utilized to
establish
recommendation were
not identified in the
report.
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Special consideration
should be given to anyone
with a hemoglobin
below 8.5 g /dl due to
increased risk of
lightheadedness or loss of
consciousness
during flight, particularly
with physical exertion during
flight.
Sickle cell disease, may be
exacerbated by reduced
oxygen
Pressures during flight.
Because such a crisis could
be life-threatening, sickle cell
patients should be advised
not to travel by air without
medical oxygen.

●○○○
Very Low

Evidence Table: Neurologic Disorders
Author/Year

Study Design
Level of Evidence

Berilgen, 2011

Retrospective Case
Reviews

Study Purpose/Study
Sample
Study Intervention
Study Outcome
Purpose: To determine
if there are specific
characteristics of
headaches associated
with air travel
Subjects: 22 cases of
headache referred to an
outpatient Neurology
clinic
Outcome:
ENT examination,
Neurologic
examination, Brain
MRI & MRA, CT of
paranasal sinus,
description of
headache by timing,
location, quality,
intensity, duration,
accompanying
symptoms, pre-existing
diseases and other
primary headache
history

Arnaiz, 2011

Case report

Alonso-Canolvas,
2011

Prospective analysis of
registry of referred
patients

52 year old woman
who experienced
sudden episode of
dyspnea and a 5minute generalized
tonic-clonic seizure
followed by loss of
consciousness. The
patient had
experienced two
similar episodes on
prior flights and had no
non-flight related
seizure activity.
Purpose: To study
neurological problems
associated with air
travel
Subjects: 77 patients
with neurologic
problems associated
with air travel
Outcomes:
Seizures, stroke,
alternative diagnosis
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Results

GRADE
Quality of
Evidence

Airplane headache
characterized as starting
suddenly during ascent and/or
descent of the aircraft, mean
duration 20 minutes, usually
unilaterally and commonly
localized to the periorbital
region. Described as severe,
stabbing or jabbing, and
generally subsides in a short
time period.

●○○○
Very Low

Authors proposed that
headache associated with
airplane travel results from
the temporary local
inflammation caused by
hypoxia or dryness in the
sinus mucosa or sinus
barotraumas.
All 22 subjects reported
headache during flight.
Headache associated with
airplane travel did not occur
in 95% of the patients in
subsequent flights when they
received naproxen sodium
(550mg) 1 hour prior to take
off.
CT of head revealed small
corticosubortical gas emboli
and subsequent thoracic CT
demonstrated a large
bronchogenic cysts on the
right lung.

53.2% (41/77) presented with
seizures of which 61% (25)
had no prior seizure history.
Long flight duration was
noted in 53.6% of the cases.
56.6% (19) subjects had a
history of regular or recent
use of drugs , especially
alcohol (14; 34.1%). 51.2
%(21) had a single seizure,
31.7% (13) multiple and
17.1% (7) had status
epilepticus. Of the 13
patients with known epilepsy,
10 had missed doses of
antiepileptics in prior days, 4
had sleep deprivation and 3
had used recreational drugs

●○○○
Very low

●●○○
Low

Stroke
23.4% (18/77) had diagnoses
of stroke. Of those affected
hypertension was noted in 10,
tobacco use in 4, cardiopathy
with high embolic risk in 4,
hypercholesterolemia in 3 and
diabetes mellitus in 1. 10.4%
(8 patients) had an ischemic
stroke and 10.4% (8 patients)
patients had an intracranial
hemorrhage.

IATA, 2011

Executive summary of
the International Air
Transport Association
of travel restrictions
based on expert
opinion

Establish a guide to the
timeframe that should
elapse between a
medical event and
commercial air travel
Studies utilized to
establish
recommendation were
not identified in the
report.

26% (20/77) cases had an
alternative diagnosis: drug
toxicity (4), non-organic
symptoms (4), syncope (2),
peripheral neuropathy (2),
delirium (2), neoplasms of the
CNS (2), viral
meningoencephalitis (1),
chronic stroke (1), migraine
with aura (1) and transient
global amnesia (1)
Patients are cleared to fly
without restriction who have
the following respiratory
conditions:

●○○○
Very Low

Transient Ischemic Attack – 2
days after evaluation
CVA 5-14 days if stable or
improving with a nurse
escort. Supplemental oxygen
is recommended the first 2
weeks after stroke
Grand mal fit ≥ 24 hours if
generally well controlled
Cranial surgery ≥ 10 days,
cranium free of air and
adequate general condition.

Parees, 2010

Case Report

Ipekdal, 2010

Case Report

Domitrz, 2010

Case Report

44 year old woman
with an acute anterior
circulation stroke after
a transatlantic flight.
Three cases of airplane
headache were
reported on in children
ages 12, 13, & 14

Case report of a
“young man” with
airplane headache
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All conditions not meeting
above requirements for
clearance should have
“assessment by a doctor with
aviation medicine experience”
(IATA, 2011 p. 54).
CT and MRA revealed a
single pulmonary
arteriovenous malformation
in the lower right lung lobe.
Barotrauma due to nasal
mucosal inflammation,
adenoidal and tonsillar
hypertrophy and sinusitis
were found to be the
causative factors for the
airplane headache.
Author posits that
pathophysiology of airplane
headache is unclear and
secondary causes must be
ruled out.

●○○○
Very low
●○○○
Very low

●○○○
Very low

Seth, 2009

Case Report

51-year-old male post
craniotomy for a
glioblastoma
multiforme and the
determination of
fitness to fly

Almeida, 2007

Case Report

62-year-old female
who became
unresponsive and rigid
20 minutes into a
commercial flight from
Denver to Omaha

Mainardi, 2007

Case Report

A case of airplane
headache was reported
in Italy

Aquilina, 2006

Case Reports

Two case reports of air
travelers – an 81-yearold male and a 74-year
old female who
experienced cognitive
impairment
precipitated by travel

Berilgen, 2006

Case Reports

Six case reports of
headache associated
with airplane travel

Trevorrow, 2006

Prospective survey

Purpose: determine if
air travel increases
seizure activity both
during and after flying,
and to identify flight
characteristics that
promote increased
seizure activity
Subjects: 37 patients
with known seizure
diagnosis
Intervention: travel by
commercial aircraft
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The authors noted concerns
for post-surgical
pneumocephalus based upon
literature review encountering
only case reports and posited
that the absence of any intracranial air is the best indicator
of fitness to fly.
Bilateral acute infarcts
associated with cerebral
edema secondary to air
emboli were noted on CT of
the head. CT of the chest
with contrast revealed a large
thin-walled cystic lesion with
a small air-fluid level
consistent with the diagnosis
of congenital cystic
adenomatoid malformation.
First Italian reported case of a
headache consistent with the
characteristics of airplane
headache.
Both cases had an association
between air travel and a
sudden decline in cognitive
function which presented
initially as delirium. The
only diagnostic changes
found on examination were
cerebral ischemia and partial
improvement occurred in both
cases after several months.
All patients were male,
suffering from severe, short
lasting, unilateral, periocular
localized cluster-like
headaches. None of the
patients had a prior history of
cluster headache. Attacks
lasted between 15-20 minutes
and resolved spontaneously.
The authors posit that
barotraumas caused by
changes in cabin pressure
during take-off and landing
could affect the ethmoidal
nerves and/or nocioceptors in
the ethmoidal arteries
activating the
trigeminovascular system
resulting in headache.
Seizures were significantly
more common after flying
(p=.02).
No in-flight seizure activity
was noted by participants
Participants experiencing an
increase in seizure frequency
had: a higher baseline seizure
frequency (p = .004), were
more likely to have
experienced increased seizure
activity after flying (p= .001),
were more worried about
having a seizure while flying

●○○○
Very low

●○○○
Very low

●○○○
Very low
●○○○
Very low

●○○○
Very low

●●○○
Low

Outcomes:
Self-monitored seizure
activity

Belvis, 2005

Case Report

36-year-old female
with no significant
medical or family
history had onset of
dyspnea followed 20
minutes later by
depressed level of
consciousness, right
hemiparesis and global
aphasia after an 11.35
hour flight from Peru
to Spain.

Kakkos, 2003

Case Report and
literature review

49-year-old male who
collapsed two days
after traveling by air
for 19 hours from
Alaska to London.

Foerch, 2003

Case Reports

Lapostolle, 2003

Case Reports

ASMA, 2003

Recommendations
based on expert
opinion for primary
care and specialist
physicians to advise
patients with medical
conditions

Report of three longdistance air passengers
(ages 21, 63 & 64
years) with first-time
neurological deficits
that occurred during
long-haul flights
Four cases of stroke
associated with
pulmonary embolism
and deep venous
thrombosis associated
with long-haul travel
Establish
recommendations for
fitness of passengers
with neurologic and
other medical diseases
to fly on commercial
airlines
Studies utilized to
establish
recommendation were
not identified in the
report.

Sirven, 2002

Retrospective review
of medical incidents
that led to flight
diversions

Purpose: analyze the
frequency of
neurologic events
during commercial
airline flights and to
assess whether
onboard emergency
medical kits were
adequate for in-flight
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(p=.001) and were more
likely to avoid air travel
(p=.02).
There was no significant
correlation between distance
traveled, time zones crossed,
duration of flight or direction
of flight with increased
seizure activity.
A pulmonary scintigraphy
demonstrated a pulmonary
thromboembolism and a
cranial MRI revealed
ischemic infarct in the left
middle cerebral artery.
The authors posit that the
appearance of a stroke
following long-haul travel
was suggestive of paradoxical
embolism through a patent
foramen ovale.
The authors located 12
similar cases of stroke
occurring in close
approximation to long-haul
flight travel. Venous
thromboembolism was parent
in 58% and patent foramen
ovale was diagnosed in all but
one case.
Embolic cerebral ischemia
with persistent foramen ovale
was found by MRI in all three
cases. No venous thrombosis
was found on scans of the
patient’s legs.

●○○○
Very low

●○○○
Very low

●○○○
Very low

Patent foramen ovale was
found to be the mechanism
for ischemic stroke in all four
cases.

●○○○
Very low

Patients with epilepsy can fly
safely but should be made
aware of the potential seizure
threshold-lowering effects of
fatigue, delayed meals,
hypoxia and disturbed
circadian rhythm if passing
through multiple time zones.

●○○○
Very Low

Patients who have had a
recent cerebral infarction or
other acute neurological event
should not travel until
neurological condition is
stable.
Neurologic symptoms were
the most frequent source of
emergency calls and the
fourth most likely cause for
flight diversion.
Incidence of symptoms:
Dizziness/vertigo (354)
Seizures (131)

●●○○
Low

neurologic
emergencies.
Subjects: 2,042
medical incidents
leading to 312
diversions between
1995-2000 reported to
the Mayo clinic air-toground medical service
Outcomes:
Neurologic symptoms
reported in-flight
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Headache (37)
Loss of
consciousness/syncope (34)
Pain (no organ system) (25)
CVA (21)
Confusion (6)
Numbness (6)
Tremor (2)
The authors posited that
pressurization of the cabin,
turbulence and hypoxemia
may be causative factors for
neurologic symptoms inflight

Evidence Table: Ophthalmology, Otolaryngology & Allergy
Author/Year

Study Design
Level of Evidence

IATA, 2011

Executive summary of
the International Air
Transport Association
of travel restrictions
based on expert
opinion

Study Purpose/
Study Sample
Study Intervention
Study Outcome
Establish a guide to the
timeframe that should
elapse between a
medical event and
commercial air travel
Studies utilized to
establish
recommendation were
not identified in the
report.

Results

GRADE
Quality of
Evidence

Patients are cleared to fly
without restriction who have
the following conditions:

●○○○
Very Low

Otitis Media & Sinusitis – if
able to clear ears and not
acutely ill
Middle ear surgery ≥ 10 days
post operatively with medical
certificate from treating ENT
Tonsillectomy ≥ 4 days
Wired Jaw – if escorted with
cutters or self quick release
wiring
Penetrating eye injury ≥ 7
days after injury
Intra-ocular surgery ≥ 7 days
post operative
Cataract surgery ≥ 24 hour
Corneal laser surgery ≥ 24
hour

Bayer, 2008

Longitudinal cohort

Purpose: to investigate
the effect of air flight
on intraocular pressure
(IOP)
Subjects: 25 healthy
volunteers
Intervention: Cruising
cabin pressure of
8,000ft

Comstock, 2008

Cross-sectional survey

Outcomes: Change in
IOP
Purpose: Characterize
reactions to foods
experienced by
passengers on
commercial planes
Subjects: 41
respondents with
known nut and seed
allergy
Outcome:
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All conditions not meeting
above requirements for
clearance should have
“assessment by a doctor with
aviation medicine
experience” (IATA, 2011 p.
54-55).
Baseline IOP 14.2 ± 2.7
mmHg. Non-significant
reduction at reaching cruising
altitude -0.2 ± 2.7 mmHg (1.4%).

●●○○
Low

Significant IOP reduction
12.3 ± 2.5 mmHg (-13.4%)
on the second hour of flight
(p=0.005) and after landing
12.0 ± 1.7 mmHg (-15.8%)
(p=0.001).
9% (41/471) respondent’s
self-reported nut and seed
allergy associated with air
travel. 10% (4/41) had
experienced more than one
reaction on an airplane.
Mode of exposure: 58%
(n=26) inhalation, 9% (n=4)
contact, 33% (n=33%)
ingestion.

●○○○
Very Low

Self-report of allergic
symptoms and severity
or reaction by
symptoms of pruritus,
urticaria, flushing,
angioedema, nasal
congestion, sneezing,
nausea vomiting, throat
tightness or throat
pruritus, diarrhea,
hoarseness, wheezing,
cyanosis, mild
hypotension or lightheadedness ,respiratory
arrest, severe
hypotension or loss of
consciousness

63% reported carrying
epinephrine although 80%
had been given a
prescription.
Peanuts were the primary
cause of reaction (73%)
followed by tree nuts (18%),
sesame seeds (4.5%) and
mixed nuts (4.5%).
80% of reactions during
flight caused moderate-tosevere symptoms by selfreport
29% (12/41) individuals
reported the reaction to a
flight attendant
32% (11/34) experiencing
moderate to severe reactions
reported the reaction a flight
attendant.

Mahmood, 2003

Cross-sectional survey

Purpose: to determine
current professional
advice to patient
related to air travel
following zygomatic
fractures
Subjects: 184 oral and
maxillofacial surgeons
(OMFS) in the United
Kingdom. 71%
response rate 184/261
questionnaires sent.

ASMA, 2003

Monaghan, 2002

Recommendations
based on expert
opinion for primary
care and specialist
physicians to advise
patients with medical
conditions

Case Report

Outcomes: Length of
time to refrain from
travelling by air
Purpose: establish
recommendations for
fitness of passengers
with medical diseases
and conditions to fly on
commercial airlines
Studies utilized to
establish
recommendation were
not identified in the
report.
Report of orbital
emphysema caused by
pressure changes
during air travel
Subject: 21 year old
male

No restrictions were advised
by OMFS for:
40% open reduction and
internal fixation
42% closed reduction
47% non-operative
management
30% advised delay of travel
for 8-14 days
15% advised delay of travel
for 3-8 weeks

Post-op facial plastic surgical
procedures, tonsillectormy &
adenoidectomy, palatoplasty,
nasal or facial fractures can
fly once postoperative
bleeding risk has passed after
clearance by their surgeon
(usually 1-2 weeks).

●○○○
Very Low

Subject hit his face on a curb
resulting in laceration repair
and routine radiological
examination after injury.
Subject flew 2 days postinjury and developed intense
pain in the affected eye and
edema of the periorbital
tissues with residual double
vision and eye pain.

●○○○
Very Low

Post-flight CT revealed an
orbital floor fracture with
large quantities of intraorbital
air with proptosis of the
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●●○○
Low

globe

Jassar, 2001

Controlled cohort
study

Purpose: evaluate
whether air travel
affects graft take rates
after myringoplasty
Subjects: 37 adult and
pediatric postmyringoplasty subjects
who traveled by air
within a week of
surgery compared with
37 matched nontraveling postmyringoplasty

No difference in take rates
between study and control
groups (p=0.32)

●○○○
Very Low

95% CI of difference in take
rates were -9% (flying group
9% worse) to 27% (flying
group 27% better).

Intervention:
45-60 minute flight
duration

Mills, 2001

Nonrandomized
comparative trial

Outcome:
Graft status at first
follow-up
Purpose: To investigate
the safety of air flight
for patients with small
volumes of residual
postoperative
intraocular gas
Subjects: 17 eye (9 gas
filled (7 with 10-15%
gas volume and 2 with
20% gas volume) and 8
control eyes) of nine
eye patients and one
eye of one control
subject
Outcome: absolute and
percentage change in
IOP with varied cabin
pressure

Results of 10-15% gas
volume group: IOP increased
an average of 109% from
baseline during ascent to an
average cabin altitude of
7429 ft. IOP decreased to
30% above baseline during
cruise altitude and further
decreased to an an average of
38% below baseline on return
to baseline altitude.
Results for 20% gas volume
group:
IOP raised an average of 84%
from baseline during ascent
and dropped to an average of
42% below baseline on return
to baseline altitude.
IOP in the contralateral
control eyes did not vary with
altitude changes.
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●●○○
Low

Evidence Table: Pregnancy
Author/Year

Study Design
Level of Evidence

IATA, 2011

Executive summary of
the International Air
Transport Association
of travel restrictions
based on expert
opinion

Study Purpose/
Study Sample
Study Intervention
Study Outcome
Establish a guide to the
timeframe that should
elapse between a
medical event and
commercial air travel
Studies utilized to
establish
recommendation were
not identified in the
report.

Magann, 2010

Literature review

Purpose: Examine
current information
available on air travel
and pregnancy
outcomes for the
frequent air traveler,
flight attendant and
female aviator.
Sample: 128 abstracts
evaluated, 9 of which
evaluated air travel and
pregnancy outcomes

ACOG, 2009

RCOG, 2008

Advisory Committee
Opinion

Advisory Committee
Opinion

Outcomes: spontaneous
pregnancy loss (SAB),
intrauterine fetal
demise (IUFD), low
birth weight (<10th
percentile), preterm
delivery and neonatal
intensive care unit
admissions.
Purpose: Consensus
statement on risk of air
travel during pregnancy

Studies utilized to
establish
recommendation were
not identified in the
report.
Purpose: Consensus
statement on risk of air
travel during pregnancy

Studies utilized to
establish
recommendation were
not identified in the
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Results

GRADE
Quality of
Evidence

Clearance not required before
36 weeks for single,
uncomplicated pregnancy or
before 32 weeks for multiple,
uncomplicated pregnancy but
doctors certificate needed
after 28 weeks.

●○○○
Very Low

Assessment by a doctor with
aviation medicine experience
is recommended beyond the
end of the 32nd week for
multiple uncomplicated,
beyond the end of the 36th
week of Gestation. For single,
uncomplicated pregnancy,
and for miscarriage
(threatened or complete) with
active bleeding.
Risk of pregnancy loss (SAB
or IUFD) was greater in flight
attendants than controls (OR
1.52, 95% CI; 1.29, 2.04).
Meta-analysis of data on SAB
alone did not reveal
significant differences in
flight attendants when
compared to controls

●●○○
Low

Risk of preterm birth <37
weeks greater in passengers
than controls (OR 1.44, 95%
CI; 1.07, 1.93)
No increased risk noted for
preeclampsia, neonatal
intensive care unit
admissions, or low birth
weight noted among groups.

In the absence of obstetric or
medical complications
occasional air travel is safe
for pregnant women.

●○○○
Very Low

There is no specific risk to
pregnancy associated with air
travel.

●○○○
Very Low

For women with
uncomplicated pregnancy and
no medical or obstetric risk
factors for complications that
would contraindicate air
travel, there is no indication

Chibber, 2006

Case-control survey

report.

to advice against commercial
air travel.

Purpose: Assess
whether air travel
increases the risk of
adverse pregnancy
outcomes

Among primagravidae
women who traveled by air
there was an increased risk of
preterm birth >34 weeks <37
weeks when compared to
controls (OR 1.5; 95% CI,
1.2, 1.8).

Subjects: 992 women
admitted for delivery at
a Saudi Arabian
hospital within a 12
month period. 55%
(546) traveled at least
once during pregnancy,
45% (447) controls
who did not travel

Freeman, 2004

Retrospective analysis

Outcomes: preeclampsia, vaginal
bleeding, birth <34
weeks, birth >34 weeks
<37 weeks, birth
weight <10 centile,
cesarean section,
admission to NICU,
stillbirth, and neonatal
death
Purpose: To evaluate if
air travel affects
pregnancy outcome

●●○○
Low

Preterm birth was noted to be
more frequent among
expatriate women traveling
long distances and frequent
flights during pregnancy.
No other outcomes had
significant increased risk
between groups

There were no statistical
differences in pregnancy
outcomes between traveling
and non-traveling women

●●○○
Low

No increased risk from
commercial aircraft
environment to normal
pregnancy.

●○○○
Very Low

Subjects: 222 women
admitted for delivery at
a gestational age >20
weeks over a 6-month
period. 53% (n=118)
traveled at least once
during pregnancy

ASMA, 2003

Recommendations
based on expert
opinion for primary
care and specialist
physicians to advise
patients with medical
conditions

Outcomes: gestational
age at delivery,
neonatal birthweight,
vaginal bleeding,
preterm delivery < 37
weeks, preeclampsia,
neonatal intensive care
unit admission or
cumulative adverse
obstetric outcome
Establish
recommendations for
fitness of pregnant
passengers with and
those with other
medical diseases to fly
on commercial airlines
Studies utilized to
establish
recommendation were
not identified in the
report.
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Evidence Table: Psychological Disorders
Author/Year

IATA, 2011

Study Design
Level of Evidence
Executive summary of
the International Air
Transport Association
of travel restrictions
based on expert
opinion

Study Purpose/Study Sample
Study Intervention
Study Outcome

Results

GRADE
Quality of
Evidence

Establish a guide to the
timeframe that should elapse
between a medical event and
commercial air travel

Patients are cleared to
fly without restriction
who have the following
psychiatric conditions:

●○○○
Very low

Studies utilized to establish
recommendation were not
identified in the report.

Bor, 2003

Retrospective study

Evaluation of 487 incidences of
physical violence on board
British aircraft. 48%;
(236/487) involved passengers.

Chronic psychiatric
disorders – properly
controlled by
medication and stable
Acute psychosis and
unstable chronic
psychiatric disorders
should be assessed by a
doctor with aviation
medicine experience
Use of alcohol 45% and
illegal smoking in the
aircraft toilet 36% were
the two main factors

●○○○
Very low

Disruptive passenger
profiles were consistent
over the four year
reporting period:
74-78% male
75% between ages 3049 years
5% business or first
class passengers

ASMA, 2003

Recommendations
based on expert
opinion for primary
care and specialist
physicians to advise
patients with medical
conditions

Establish recommendations for
fitness of passengers with
medical diseases to fly on
commercial airlines

Smart, 2003

Case Reports

Analysis of 29 air rage cases
reported to Canadian Press
from 1998-2000

Matsumoto, 2001

Retrospective study

Purpose: Ascertain the
incidence of in-flight
psychiatric emergencies, their
associated factors and
outcomes.

Studies utilized to establish
recommendation were not
identified in the report.

On average 22
passengers/year
required physical
restraint
Persons with
psychiatric disorders
whose behavior is
unpredictable,
aggressive,
disorganized, disruptive
or unsafe should not
travel by air. Patients
with psychotic
disorders who are
stabilized on
medication and are
accompanied by a
knowledgeable
companion may be able
to fly. (ASMA, 2003, p.
A13)
Use of excessive
alcohol and tobacco
smoking were most
important precipitating
factors.
3.5% (48/1375) calls
were categorized as
psychiatric
emergencies.
Mean age of affected
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●○○○
Very low

●○○○
Very low

●○○○
Very low

Subjects: 1375 in-flight calls
for physician consultation of
company providing consult to
24% of the flights within the
U.S. during the time of the
events.

passenger was 39.6 yr,
median 35 yr

Outcomes: events categorized
as psychiatric/psychological
emergencies

90% (43/48) were for
anxiety
4% (2/48) psychosis
4% (2/48) nonpsychotic disruptive
passenger
2% (1/48) conversion
disorder
No incidences of air
rage or other aggressive
behaviors were
reported.
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73% of calls (35/48)
were for female
passengers

Evidence Table: Diabetes
Author/Year

Study Design
Level of Evidence

King, 2011

Quasi-experimental

Study Purpose/Study
Sample
Study Intervention
Study Outcome
Purpose: study the effects
of atmospheric pressure
during airplane flight on
insulin pump delivery
Subjects: 10 insulin
pumps(5 Animas 2020
and 5 Medtronic
Paradigm)
Intervention:
Outcome: insulin delivery

Hinninghofen, 2006

Two by two repeated
measurement design
Simulated in
hypobaric chamber

Purpose: To evaluate the
effects of altitude and diet
on gastric emptying
cardiovascular function
and bodily complaints
Subjects:16 healthy
volunteer adults
Intervention: Hypobaric
chamber simulated flight
altitude of equivalent to
8200 ft
Outcomes:
Heart rate, gastrointestinal
symptoms of distension,
bloating, belching and
gastric emptying assessed
by 13C-octanoic acid
breath test.

Burnett, 2006

Census study selfadministered
questionnaire

Purpose: To determine
types of problems
experienced by people
with diabetes mellitus
while traveling by air
Subjects: 493 (37.1%
response rate) patients
using insulin from a clinic
in Aberdeen UK over a
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Results

GRADE
Quality of
Evidence

During ascent both pumps
delivered excess insulin
(Animas 1.37 units (u) and
Medtronic 1.01 u)
(P<.001)

●●●○
Moderate

During descent both
pumps delivered a deficit
of insulin (Animas 0.87 u
and Medtronic 0.58 u)
(P<0.01)
Unintended insulin
delivery was determined to
be due to air coming out of
the solution and forming
bubbles when the pressure
decreased. Bubbles
displace insulin in the
pump causing excess
delivery. During descent,
increase in air pressure
leads to the bubbles
redissolving which stops
insulin delivery until the
deficit is replaced.
Mechanical function was
not affected by changes in
ambient pressure.
Heart rate increased
throughout the simulation
independent of the dietary
condition. (p=0.011)

●●●○
Moderate

At 8200 ft altitude gastric
emptying was significantly
delayed when a high-fiber
meal was given (146.3 ±
48.4 min low fiber vs.
193.9 ± 54.3 m high fiber;
p= 0.039).
The symptom score for
gastric distention (1.33 ±
0.3 vs. mean 1.07 ± 0.15; p
= 0.022) and bloating
(1.82 ± 0.47 vs. mean 1.34
± 0.35; p=0.015) were also
significantly increased at
8200 ft altitude for the
high-fiber meal compared
with the low-fiber meal.
94% denied experiencing
problems related to air
travel. Those with
difficulty noted difficulty
in obtaining diabetic meals
ordered or low blood sugar
due to delay in meal
delivery.
91% carried food with

●●○○
Low

period of 3 months
Outcomes:
hypoglycemia

them for the journey.
More men than women did
not take additional food (x2
= 5.54, p = 0.019).
15% of insulin users did
not inform any airline
personnel of their diabetes.
8 patients (x2 = 4.84, p =
0.028) did not carry
identification of their
disease on their person.
20.1% of long-haul
travelers and 32.1% of
short-haul travelers
experienced delays. 10%
of delayed travelers
experienced difficulties
due to late meals as a
result of the delay.
10.2% of both long and
short haul travelers
experienced hypoglycemia
while traveling abroad and
for the first 24 hours after
arrival. Hypoglycemia
was more likely to be
delayed until the first 8
hours after arrival at the
destination in the longhaul group and was less
likely to be severe. 31% of
those experiencing
hypoglycemic
symptoms described them
as severe and requiring
help.
Hyperglycemia while
traveling was more likely
to occur in long-haul
travelers than short-haul
travelers (x2 = 10.1,
p=0.00)

ASMA, 2003

Recommendations
based on expert
opinion for primary
care and specialist
physicians to advise
patients with medical
conditions

Establish
recommendations for
fitness of passengers with
medical diseases and
conditions to fly on
commercial airlines
Studies utilized to
establish recommendation
were not identified in the
report.

50% of long-haul and
41.6% of short-haul
travelers sought advice
about managing their
diabetes while traveling
Diabetic travelers under
reasonable control can fly
anywhere safely if they
plan in advance and
discuss the proposed
journey with their
healthcare provider.
Travel crossing several
time zones and depending
on the direction traveled
may shorten or lengthen
the 24 hour day which
may require adjustments in
insulin regimens.
The use of short-acting
soluble insulin or fast-
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●○○○
Very low

acting insulin analogues
during long flights is
recommended.
Traveling east the day is
shortened by 2 hours and
there may be the need to
take fewer units of
intermediate or long acting
insulin. Conversely
traveling west may require
supplemental injections or
increased dosing of
insulin.
On the first morning of
eastbound travel at the end
destination 2/3 dose of the
usual morning dose of
insulin should be taken to
account for the decreased
hours since the previous
morning’s injection.
When traveling
westbound, no adjustments
in daily dosing need to be
made.
Type 1 diabetics should
carry additional
carbohydrate to cover
meal delayed meals,
should consider alerting
flight crew to their
condition and should have
accessible identification on
their person.
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APPENDIX G: CLINICAL PRACTICE GUIDELINE
Guideline Title
Guideline for Passenger Fitness to Fly Evaluation in Primary Care
Bibliographic Source
Pending acceptance by peer-reviewed journal
Guideline Status
This is the current recommendation report pending review by expert panel prior to
dissemination.
FDA Warning/Regulatory Alert
Not applicable as no drugs or devices are recommended in this guideline
Scope
Disease/Condition(s)
Cardiovascular disease (CVD)
Pulmonary disease
Deep Vein Thrombosis/Venous Thromboembolism
Neurologic disease
Ear, eye, nose and throat disease
Pregnancy
Psychiatric disorders
Diabetes mellitus
Guideline Category
Counseling
Evaluation
Management
Prevention
Risk Assessment
Screening
Clinical Specialty
Family Practice
Internal Medicine
Obstetrics
Pediatrics
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Preventive Medicine
Travel Medicine
Intended Users
Advanced Practice Nurses
Health Care Providers
Physician Assistants
Physicians
Guideline Objective
To identify medical conditions that may be affected by the physiologic and
pathologic effects of commercial air travel
To assist the primary care provider in making fitness to fly decisions to improve
practice
Target Population
Any patient planning commercial air travel particularly those with pre-existing
medical conditions
Interventions and Practices Considered
1. Screening for pre-existing medical conditions that may be adversely affected by
commercial air travel
2. Assessment of fitness to fly
Management/Prevention
1. Management of specific patient populations
Patients with cardiovascular conditions
Patients with respiratory conditions
Patients with risk for venous thromboembolism
Patients with neurologic conditions
Patients with eye, ear, nose and throat conditions
Patients who are pregnant
Patients with psychiatric conditions
Major Outcomes Considered
Morbidity and Mortality associated with commercial air travel
Quality of life
Adherence to lifestyle modifications
Methodology
Methods Used to Collect/Select the Evidence
Searches of Electronic Databases
Description of Methods Used to Collect/Select the Evidence
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Medline, PubMed, the Cochrane Library CINAHL (EBSCOHost), and other
electronic sources for admissible evidence or studies published between February
2001 and February 2012. Search terms included air, plane, aircraft, travel,
airline, fitness to fly, commercial air, hypoxia, hypoxemia, pre-flight, post-flight,
cardiovascular, circulatory, blood, hematology, anemia, pulmonary, COPD,
respiratory, asthma, restrictive lung, non-restrictive lung, neurologic, neurology,
central nervous system, gastrointestinal, abdomen, ear, nose, throat, psychiatric,
anxiety, psychosis, eye, ophthalmologic, pregnancy, children, pediatric,
orthopedic, surgical, surgery, trauma, disease, infection, pain, and prevention.
Identified studies were limited to those written in English or with available
English translations. Expert opinion and guidelines developed by other sources
were included in the guideline development and all efforts were be made to
correlate opinion and published guidelines to primary sources of research.
Number of Source Documents
72 articles were included in the evidence review.
Methods Used to Assess the Quality and Strength of the Evidence
Weighting according to the Rating Scheme (Scheme Given)
Rating Scheme for the Strength of the Evidence
Level of evidence Qualifying Studies
High (4)
●●●●
Moderate (3)
●●●○
Low (2)
●●○○
Very Low (1)
●○○○

High-quality, multi-centered or single-centered, randomized
controlled trial with adequate power; or a systematic review of these
studies
Lesser-quality, randomized controlled trial; prospective cohort study;
or a systematic review of these studies
Retrospective comparative study, case-control study or a systematic
review of these studies
Case reports, expert opinion or evidence based on physiology

*Evidence level can be increased or decreased based upon study quality directness and
strength of association.
Methods Used to Analyze the Evidence
Systematic Review
Description of the Methods Used to Analyze the Evidence
The supporting literature was critically appraised for study quality according to
criteria referenced in key publications on evidence-based practice. Depending on
the study design and quality, each reference was assigned a corresponding level of
evidence (High-Low) and the evidence was synthesized into practice
114

recommendations.
Methods Used to Formulate Recommendations
Expert Consensus (pending)
Description of Methods Used to Formulate Recommendations
Systematic Review
Rating Scheme for the Strength of the Recommendations
Grade

Descriptor

Qualifying
Evidence

Implications for
practice

A

Strong
Recommendation

Level 4 evidence or
consistent findings
from multiple studies of
levels 3, 2 or 1

B

Recommendation

Levels 3, 2 or 1
evidence and findings
are generally consistent

C

Option

Levels 3, 2 or 1
evidence and findings
are inconsistent

D

Option

Little or no systematic
empirical evidence

Primary care providers
should follow a strong
recommendation unless
a clear and compelling
rationale for alternative
approach is present
Primary care providers
should follow a
recommendation but
should monitor new
information and be
sensitive to patient
preference.
Primary care providers
hold be flexible in their
decision-making
regarding appropriate
practice, although they
may set bounds on
alternatives; patient
preference should have
a substantial
influencing role.
Primary care providers
should consider all
options in their
decision-making and
monitor for new
published evidence that
clarifies the risk versus
benefit; patient
preference should have
a substantial
influencing role.

Cost Analysis
A cost analysis was not performed and published cost analyses wee not reviewed.
Method of Guideline Validation
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Comparison with guidelines from other groups
External peer review
Internal peer review
Description of Method of Guideline Validation
The guideline will be submitted for approval by the International Society of
Travel Medicine.
Recommendations
Major Recommendations
Definitions for the levels of evidence (1-4) and the grades of the recommendations (A-D)
are provided at the end of the “Major Recommendations” field (Appendix G).
Recommendations
Cardiovascular Conditions/Disorders
Patients with hemodynamically stable,
asymptomatic cardiac conditions without recent
changes in symptoms or medications should not be
restricted from travel by commercial air
Chronic Heart Failure – clear to fly if able to climb
one flight of stairs or walk 50 meters at normal
pace without breathlessness. Flying
contraindicated for severe, decompensated
conditions. Consider supplemental O2 for NYHA
class IV or those with comorbid conditions which
may impact oxygenation.
Cardiac Surgery – travel should be delayed for at
least 10 days post operatively without
complications. Additional ground support may be
needed to meet the travel to/within/from the
airport.
Angiography – cleared to fly ≥ 24 hours after
procedure if condition is stable
Angioplasty - cleared to fly ≥ 3 days after
procedure if asymptomatic
Eisenmenger Syndrome – consider O2 in flight
Cardiac conditions or procedures requiring
anticoagulation – delay travel until stable
anticoagulation levels achieved
Pacemakers and ICDs – delay travel one days post
placement if asymptomatic and no pneumothorax
** Supplemental and in-flight oxygen should be
considered to meet the additional physical demands of
travel to/within/from the airport to destination as well
as for potential hypoxemia associated with hypobaric
aircraft cabin conditions for any patient with labile
health condition or with cormobidity that may affect
oxygenation.
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Supporting Evidence
Ingle et al., 2011; IATA, 2011;
Smith et al., 2010; ASMA, 2003;
Roby, Lee, & Hopkins, 2002;
Zahger, Leibowitz, Tabb & Weiss,
2000

Grade
C

Recommendations
Respiratory Conditions/Disorders
Patients with stable, asymptomatic respiratory
conditions with full recovery from any
exacerbation and an exercise tolerance of >50
meters without dyspnea can be cleared to fly
without restrictions
Pneumothorax and pleural effusion- delay travel
for at least 7 days after full inflation
Chest surgery – clear to travel once free from
residual air.
Pulmonary arteriovenous malformation (PAVM)
and pulmonary cysts – advise significant caution
against travel by air due to high risk for venous
thromboembolism (VTE), stroke and sudden death.
Any condition where pre-flight SpO2 <89% of
PaO2 <70 mmHg, in-flight oxygen should be
considered

Supporting Evidence
Akero et al., 2011; Tam et al., 2011;
Bossley et al., 2011; Edvardsen et
al., 2011; IATA, 2011; Thamm et al.,
2011; Ahmedzai et al., 2011;
Tiemensma, Buys & Wadee, 2010;
Lapostolle et al., 2009; Kelly et al.,
2009; Lehmann et al., 2009; TaveiraDaSilva et al, 2009; Martin et al,
2008; Kelly et al., 2008; Jones et al,
2008; Broberg et al, 2007; Currie,
Kennedy, Paterson, & Watt, 2007;
Udomittipong et al., 2006; Kelly et
al., 2006; Almeida et al., 2006;
Humphreys et al., 2005; Closon et
al., 2004; ASMA, 2003; Lee,
Yamamoto, & Relles, 2002

Grade
C

** Supplemental and in-flight oxygen should be
considered to meet the additional physical demands of
travel to/within/from the airport to destination as well
as for potential hypoxemia associated with hypobaric
aircraft cabin conditions for any patient with labile
health condition or with comobidity that may affect
oxygenation.

Recommendations
Venous Thromboembolism Risk
Prior history of Cerebral emboli, PE, VTE or DVT
should have ultrasound screening before clearance
to fly to rule out presence of asymptomatic
thrombus
Patients on anticoagulation therapy should be
stable at therapeutic level before clearance to fly
Flight times or multiple short leg air travel >4
hours within 4 weeks increases risk of VTE 2-4
fold
Anemia and Bleeding disorders
Caution should be advised to patients with
hemoglobin levels below 8.5 g /dl due to increased
risk of lightheadedness or loss of consciousness
during flight, particularly with physical exertion
during flight.
Patients with Sickle cell disease need to be made
aware that their condition can be exacerbated by
reduced oxygen pressures during flight. Because
such a crisis could be life-threatening, sickle cell
patients should be advised not to travel by air
without medical oxygen.
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Supporting Evidence

Grade

MacCallum et al., 2011; Schreijer, et
al, 2010; Chandra et al., 2009;
Schreijer et al., 2008; Kuipers et all,
2007; WHO, 2007; Philbrick et al.,
2006; Aryal et al., 2006; Schwarz et
al., 2003; Jacobson et al., 2003

B

IATA, 2011 & ASMA, 2003

D

Neurologic Disorders
Stable CNS disorders without recent exacerbation
or prior history of event associated with air travel
do not require restrictions.
History of CNS changes in prior air travel should
be a contraindication for travel until complete
cardiopulmonary and CNS examination has been
performed
CVA – delay travel at least two weeks post event
unless medically escorted with supplemental O2
Seizure Disorder/Epilepsy – clear to fly if stable on
medications and no recent change in dosage.
Caution patient regarding seizure-threshold
lowering effects of ETOH, fatigue, delayed meals,
hypoxia and disturbed circadian rhythm. Advise
patient to carry identification and medication on
person during travel.
Headache (in absence of migraine history or other
CNS disorder) associated with ascent/descent may
respond to Naproxen 550 mg po one hour before
take-off
Ophthalmology, Otolaryngology & Allergy
Cataract or corneal laser surgery – delay travel for
24 hours after procedure
Intra-ocular surgery or penetrating eye injury –
delay travel for 7 days after injury or procedure
Ophthalmologic conditions negatively affected by
changes in intra-ocular pressure should avoid
travel
Orbital, zygomatic or sinus surgery – delay travel
until bleeding risk controlled and cleared by
surgeon
Tonsillectomy delay travel for at least 4 days after
surgery or control of active bleeding
Patients with known significant allergy-sensitive
conditions should travel with antihistamines and
epinephrine as medically indicated.
Passengers with pet allergies should be aware of
the possible contact or inhalation of pet dander
from cabin-traveling animals.
Passengers with peanut, nut or seed allergies can
avoid potential inhalation exposure by requesting
information in advance from the airline. Note, as
many passengers are now carrying food on planes,
the likelihood of inhalation exposure can still exist.
Pregnancy
Pregnancy is not a contraindication for air travel
*Airlines may require clearance to fly for pregnant
women >28 week gestation.
**The availability of OB/GYN services at the travel
destinations should be weighted into passenger’s
decision to travel by air.
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MacCallum et al., 2011; Schreijer, et
al, 2010; Chandra et al., 2009;
Schreijer et al., 2008; Kuipers et all,
2007; WHO, 2007; Philbrick et al.,
2006; Aryal et al., 2006; Schwarz et
al., 2003; Jacobson et al., 2003

C

IATA, 2011; Bayer et al., 2008;
Comstock et al., 2008; Mahmood et
al., 2003; ASMA, 2003; Monaghan
et al., 2002; Jassar et al., 2001; Mills
et al., 2001

D

IATA, 2011; Magann et al., 2010;
ACOG, 2009; RCOG, 2008; Chibber
et al., 2006; Freeman et al., 2004,
ASMA, 2003

B

Psychiatric Disorders
A stable, controlled, psychiatric condition is not a
contraindication to air travel. Acute psychosis and
unstable chronic psychiatric disorders should be
assessed by a doctor with aviation medicine
experience

IATA, 2011; Bor et al, 2003; ASMA,
2003; Smart et al., 2003; Matsumoto
et al., 2001

Diabetes Mellitus
Patients with diabetes controlled by insulin pump
should monitor blood sugars closely during travel
by air
Diabetics should carry medical condition
identification, medications and on person

King et al., 2011; Hinninghofen
et al, 2006; Burnett et al., 2006;
ASMA, 2003

D

D

Definitions:
Evidence Rating Scale for Studies Reviewed
Level of evidence
High (4)
●●●●

Qualifying Studies
High-quality, multi-centered or single-centered, randomized controlled trial with adequate power; or a
systematic review of these studies

Moderate (3)
●●●○
Low (2)
●●○○
Very Low (1)
●○○○

Lesser-quality, randomized controlled trial; prospective cohort study; or a systematic review of these
studies
Retrospective comparative study, case-control study or a systematic review of these studies
Case reports, expert opinion or evidence based on physiology

Scale for Grading Recommendations
Grade
A

Descriptor
Strong Recommendation

Qualifying Evidence
Level 4 evidence or
consistent findings from
multiple studies of levels 3, 2
or 1
Levels 3, 2 or 1 evidence and
findings are generally
consistent

B

Recommendation

C

Option

Levels 3, 2 or 1 evidence and
findings are inconsistent

D

Option

Little or no systematic
empirical evidence

Implications for practice
Primary care providers should follow a strong
recommendation unless a clear and
compelling rationale for alternative approach
is present
Primary care providers should follow a
recommendation but should monitor new
information and be sensitive to patient
preference.
Primary care providers hold be flexible in
their decision-making regarding appropriate
practice, although they may set bounds on
alternatives; patient preference should have a
substantial influencing role.
Primary care providers should consider all
options in their decision-making and monitor
for new published evidence that clarifies the
risk versus benefit; patient preference should
have a substantial influencing role.

Clinical Algorithm(s)
None provided
Evidence Supporting the Recommendations
References Supporting the Recommendations
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Types of Evidence Supporting the Recommendations
The type of supporting evidence is identified and graded for each
recommendation (see “Major Recommendations”).
Benefits/Harms of Implementing the Guideline Recommendations
Potential Benefits
These guidelines will assist primary care providers in the screening and clinical
decision-making regarding clearance to fly for their patients with pre-existing
medical conditions that may be adversely affected by commercial air travel.
Potential Harms
Risks inherent in commercial air travel, which can be minimized through
appropriate patient screening and adherence to recommended practices.
Qualifying Statement
The recommendations are provided only as assistance to primary care providers
making clinical decisions regarding the care of their patients by providing a
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framework for screening and assessment. It is not intended to replace or
substitute for individual provider judgment made in each clinical situation.
The recommendations reflect the best understanding of the science of medicine
available at the time of publication. Guideline implementation should be used
with the clear understanding that continued research may result in new knowledge
and recommendations.
This guideline has several limitations, largely due to the paucity of clinical
research in the areas and limitations in the available evidence base. Further
research is needed to establish more accurate incidence of morbidity and mortality
as well as improved methods of screening for fitness to fly.
Implementation of the Guideline
An implementation strategy is pending peer review.
Institute of Medicine (IOM) National Healthcare Quality Report Categories
IOM Care Need
Living with Illness
Staying Healthy
IOM Domain
Effectiveness
Patient-centeredness
Identifying Information and Availability
Pending peer review and approval of guidelines
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